A method of treating a pathological syndrome and drug

 

(57) Abstract:

The invention relates to medicine, in particular to the treatment of various diseases. To do this, enter the activated forms of ultra-low doses of antibodies to antigen-substance involved in the mechanisms of development of pathological process. Such a substance include endogenous factors that induce disease, and drugs for the treatment of this disease. The activated form of antibodies prepared according to homeopathic technology. The proposed medicinal product containing such antibodies. The invention provides a reproduction activity of the antigen in a modified form, contributing to the reduction of the pathological process without the side effects of treatment. 4 C. and 8 C.p. f-crystals.

The invention relates to medicine and can be used to obtain medicines without side effects, and treatment of various diseases.

In the prior art it is known the use of antibodies for the treatment of pathological syndromes (SU 1331508 And a 61 K 39/00, 1984; SU 1730144 A1, 12 N 7/00, 1992).

Also known drugs (serum immunoglobulins) on the basis of the antibodies used in therapeutic dose However, the scope of these drugs is limited etiological treatment is mainly infectious diseases, and their use may be associated with undesirable side effects.

The invention is aimed at improving the treatment of pathological syndromes through the use of activated forms of antibodies on fundamentally new evidence for the regulation of pathological syndrome, as well as on the creation of drugs that have no side effects.

The solution of this problem is provided by the fact that the method of treating a pathological syndrome includes the introduction into the body of activated forms of ultra-low doses of antibodies obtained by repeated consecutive dilution in combination with treatment, the antigen is a substance or drug, influencing the formation mechanisms of pathological syndrome, or substance (drug), the introduction of which in the body, including non-medical purposes directly cause the formation of pathological syndrome.

Thus, appropriate use of activated forms of ultra-low doses of antibodies, prepared according to homeopathic technology.

It is possible to introduce into the body of activated forms of ultra-low doses of antibodies to viestnik formation of pathological syndrome or directly causing the formation of pathological syndrome.

In addition, the solution of this problem is provided by the fact that the medicinal substance contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to the substance or medicinal drug, affecting the regulation of the disturbed functions, prepared by multiple consecutive breeding and external influences, mainly on homeopathic technology.

Use of activated forms of ultra-low doses of antibodies to exogenous antigens, endogenous origin; autoantigens; to fetal antigens; antiidiotypic antibodies.

Received in accordance with the invention medicines represent a new class of pharmacological agents, which are characterized by specific pharmacological activity, lack of side effects while maintaining therapeutic action, environmental purity and low cost.

The drug can be prepared as follows.

1. Antibodies

Polyclonal antibodies that specifically bind to various compounds - proteins, Pauline is mi (haptens) receive active immunization of animals. For this purpose a specially designed circuit animals make a series of injections of the antigen, which is either individually selected high-molecular substance, or is a synthetic conjugate in the case of haptens. As a result of this procedure is to get the monospecific anticigarette with a high content of antibodies, which are used in further work. If necessary, conduct the purification of antibody present in anticigarette. For this purpose apply the salt fractionation by precipitation or ion exchange chromatography.

Monoclonal antibodies of different specificity, interacting with low molecular weight haptens and epitopes of high-molecular substances, produced using hybridoma technology. Moreover, the initial stage of the process includes immunization, based on the principles already developed in the preparation of polyclonal antisera. Further stages include obtaining hybrid cells that produce clones of the same specificity of antibodies. Their separation into individual form is carried out in the same manner as in the case of polyclonal antisera.

Natural is Odom affinity chromatography. For this purpose, as immunosorbent assay using media with covalently bound antigen which is either the hapten, or a macromolecular compound. As a result of chromatography receive a population of antibodies with narrow distribution in specificity and affinity.

Methods of obtaining antibodies are described, for example, in the book: Immunological methods/ edited, Primes, M.: Medicine, 1987, S. 9-33.

Selected antibodies to the substance or medicine sequentially repeatedly diluted and subjected to external influence to obtain a midget or small doses, for example, by homeopathic technology potentiation (see Homeopathic medicines. A guide to description and manufacturing, W. Schwabe, Moscow, 1967, S. 12-38). This produces a uniform decrease in the concentration by serial dilution of 1 volume part of the original substance (antibody) 9 volume parts (for decimal dilution (D) or 99 volumetric parts (for centesimal dilution (C) neutral solvent with multiple vertical shaking each received cultivation and use mostly separate containers for each subsequent intelligence is also possible to carry out ultrasound or other mechanical or electromagnetic effects.

Using thus prepared drug, mainly taken in homeopathic practice, pharmaceutical forms and dilutions, in the form of alcoholic or aqueous solutions or tablets (pellets) obtained by soaking before saturation is contained in the dosage form filler potentiated solution or direct introduction of the latter in liquid dosage form.

Below is an example of obtaining a medicinal product in the form of an activated form of polyclonal antibodies (antisera) to morphine.

1. Getting conjugate morphine-ovalbumin

A solution of 50 mg (0.001 mmol) ovalbumin in 5.0 ml of distilled water was mixed with 2.0 ml of dimethylformamide containing 15,0 mg (0,039 mmol) of 6-hemisuccinate morphine, and cooling was added dropwise a solution of 15 mg (by 0.055 mmol) of water-soluble carbodiimide in 3 ml of distilled water. The reaction mixture was incubated for 5 h at 4oC. the resulting conjugate was isolated by gel chromatography on a column of Sephadex G25 and freeze-dried.

The number of attached morphine was calculated according to the UV-spectra of the original protein and the conjugate change Pavlodar CLASS="ptx2">

2. Getting monospecific serum to conjugate morphine-ovalbumin

Immunization of rabbits breed "Viennese blue" weighing no more than 2kg carried out cyclically with a 10-day intervals. The maximum number of injections was four. The conjugate was injected in the forelimbs and hind limbs in the articular region of the lymph nodes in the amount of 1 mg per immunization. For this antigen was pre-dissolved in 1 ml of complete adjuvant's adjuvant. The volume of the mixture for immunization - 2 ml.

Subsequent immunization was performed using incomplete adjuvant-blockers, observing the above proportions of antigen and adjuvant. Test blood for analysis was obtained from the marginal ear vein of the animal 10 days after immunization.

The serum of the rabbits was obtained by centrifugation at 1000 g for 10 min at room temperature, after which was added as preservative chloroform to a final concentration of 13%.

The resulting anticigarette was checked by enzyme-linked immunosorbent assay for the presence of specific antibodies to morphine, the identification of which was performed using conjugate antivitamin antibodies labeled with enzyme.

Thus obtained anticavity the Li-globulin fraction. For this purpose used the deposition of protein 50% ammonium sulfate, followed by washing the precipitate 30% salt solution by centrifugation and dialysis against phosphate buffer. Thus prepared, the fraction containing specific antibodies to the antigen used in the future was used to prepare a medicinal product.

3. Getting activated form (smallest dose) of antibodies to morphine

0.5 ml fractions-globulin antisera were placed in a container of E-61, was added to 4.5 ml of distilled water, was dissolved in 10 times, received 5 ml of the 1st centesimal dilution. 0.05 ml of which was placed in the tank E-62, was added of 4.95 ml of distilled water, was dissolved in 10 times, received 5 ml of the 2nd centesimal dilution. Similarly, the 2nd SITENAME breeding was prepared from 3rd to 29th centesimal dilution. 30th somenoe breeding were obtained by breeding 29th in 20% ethanol. The resulting alcoholic solution used for treatment.

Below are examples of the treatment of various pathological syndromes of the activated form of ultra-low doses of antibodies, which are conventionally (by analogy with the terminology used in the homeopathic literature) named potentialimproving University. Long time suffering from insomnia, manifested violation of falling asleep. History moved hepatitis (possibly hepatitis and, as a consequence, changes the metabolism of xenobiotics in the liver due to the manifestation of the aftereffects of the drug). Within six months with a frequency of 2-3 times a week takes IMOVAN (7.5 mg at night). The next morning notes drowsiness, dizziness. The dose reduction to 1/2 tablet does not give the desired hypnotic effect. After the abolition of IMOVANE treatment potentiated antibodies to IMOVANE C200 tablets, two weeks dizziness and drowsiness in the morning disappeared. Sleep is normalized.

C. Patient R., 62, has complained of sleep disorders - revival in 2-3 hours at night. Previously took hypnotics group barbiturates abandoned due to lower efficiency. The recommended intake of 25% alcohol solution potentiated monospecific antisera to MIDAZOLAM (dormicum, flormidal) (8-chloro-6-(2-forfinal)-1-methyl-4H-imidazo[1,5-a] [1,4] benzodiazepine hydrochloride) 10 drops before bedtime. 3 days after the beginning of reception marked improvement in sleep, longer sleep until 7am Recommended will continue the Central gravity. The next morning marked the complaints tremor, incoordination. After a single dose of 15 ml aqueous solution of potentiated monoclonal antibodies to NITRAZEPAMA (radedorm-1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepine-2-one) C30 patient fell asleep. The conclusion about the effectiveness of this drug in restoring sleep when relief of alcohol withdrawal syndrome.

D. Patient R., 48 years in the profession, the driver, had complained of sleep disturbances caused by fatigue. To relieve insomnia proposed for intranasal potentiated aqueous solution C20 antibody to ZOLPIDEM (N, N, 6-trimethyl-2-(4-were) imidazole [1,2-a] pyridine-ndimethylacetamide) 0.5 ml at night. When you call after 5 days, the patient noted normalization of sleep. Examination revealed no reduction of reflexes and muscle tone. The conclusion about the possibility of the drug to patients whose work requires precise coordination of movements.

That is, the Patient M, 54 years old, complained of drowsiness, impaired coordination. In the long history of taking sleeping pills. After conducting a 7-day course of treatment with potentiated solution Manager 4-methyl-1-piperazinecarboxamide acid) with50 1 tablet 2 times a day, there was an increase of motor activity, normalization of sleep.

Example 2. Potentiated antibodies to the means for anaesthesia

A. the Patient M, 36 years after surgery (appendectomy) complained of nausea. Anaesthesia was used THIOPENTAL SODIUM (5-ethyldihydro-5-(1-methylbutyl)-2-thioxo-4,6-(1H, 5H)-pyrimidinedione monosodium salt). In the postoperative period for oral administration was appointed anticavity to thiopental in homeopathic dilution C30 20 ml 3 times a day, which helped to reduce symptoms of nausea.

C. the Patient P., 28, had complained of cramps in the lower extremities, hypertonicity calf muscles. Assigned oral administration potentiated the antisera to the SODIUM OXYBUTYRATE (4-hydroxybenzoic acid sodium salt) in breeding C200 15 ml before going to sleep. When viewed through 5 days decreased muscle tone.

C. the Patient M, 6 years old, was admitted to the ENT Department for inspection after the earlier tonsillectomy. The oral administration of a solution C30 potentiated antibodies to KETAMINE[(+-)-2-(2-chlorophenyl)-2-(methylamino) cyclohexanone hydrochloride] reduced the sensitivity of the mucous and perform a visual inspection.

D. Patient A., aged 47, po hiccups and tachycardia. Assigned a single oral administration of 50 ml homeopathic solution C30 monoclonal antibodies to etomidate. After 30 min was observed disappearance of hiccups and normal heart rhythm.

That is, the Patient D., 68 years old, was admitted to the surgical clinic for routine operations adenoma of the prostate gland. 3 years ago in connection with urolithiasis was operated under USING (1,1,1-Cryptor-2-chloro-2-bromatan) anesthesia. In the postoperative period was marked disturbances of liver function, often dyspeptic disorders hyperbilirubinemia, positive liver samples. There are instructions on intolerance patients of other drugs. In this regard, as drugs for the operation were used potentiated antibodies to halothane gas intravenous slow injection of 3 ml of 5% glucose solution. The operation and subsequent postoperative period were uneventful.

Example 3. Potentiated antibodies to anticonvulsant tools

A. Patient Century , 19 years. With 5 years suffer from generalized epilepsy (combination of large seizures psychomotor poverty). By the selection of drugs is most effective identified THOSE who Yan. The doctor asked the mother of the patient in connection with the appearance in the last 10 days numerous bruises on the body of the patient that are not related to mechanical injuries. Clinical blood analysis found a decrease in white blood cell count (2,9103/µl), and platelets (100103/µl). Treatment potentiated monoclonal antibodies to C30 dibenzazepine group, the basis of drug molecules. TEGRETOL cancelled. Within 2 weeks, the blood picture was normal, epileptic seizures were observed.

Example 4. Potentiated antibodies to antiparkinsonian drugs

A. the Patient Z., 37 years. After suffering encephalitis developed symptoms of Parkinson's disease. Takes good effect PARLODEL (2-Bromo-a-ergocryptine) at a dose of 10 mg/day. (table 4.). Complains of fatigue, headache, constipation. Treatment potentiated antibodies to 2-bromo-a-ergocryptine in breeding S 1 tablet in the morning daily. After 3 weeks the intestinal function is normalized, headache decreased complaints about fatigue persisted.

C. Patient E., 72 years. In connection with Parkinson's disease taking LEVODOPA (3-hydroxy-1-ti is their dose of LEVODOPA contributes to worsening of the underlying disease. The use of potentiated polyclonal antibodies to the LEVODOPA C200 1 tablet 2 times a day improved tolerability.

Example 5. Potentiated antibodies to brain

A. Patient E. , 42, enrolled in a mental hospital in a state of agitation against the background of alcohol intoxication. Through 1/4 h after intravenous injection of 1 ml aqueous solution of potentiated antisera to haloperidol (4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-forfinal)-1-butanone decanoate) C30 5% glucose was observed mild excitation, the patient fell asleep.

C. Patient L., 50 years, complained about the lack of coordination of movements. When examination revealed reduced reflexes of the lower extremities, knee and Achilles. History long (1.5 months) receiving Fluphenazine (moditen). On the background of the drug assigned intranasal administration of an aqueous solution C30 monoclonal antibodies to Fluphenazine(4-[3-[2-(Trifluoromethyl)-10H-phenothiazines-10-yl] propyl] -1-piperazineethanol) and 1 ml intravenously slowly once a day. After 4 days was observed normalization of gait, increased muscle tone of the lower extremities.

C. Patient R. , 62, appealed with complaints about treatment by oral administration of a homeopathic dilution of antisera to AZALEPTINUM (clozapine, leponex) (8-chloro-11-(4-methyl-1-piperazinil)-5H-dibenzo[b,e] [1,4] diazepin) C200 10 ml before going to sleep. After 7 days indicated the disappearance of phobias, normalization of sleep.

D. Sick Hours, 45 years old, complained of tremor and incoordination. History of long-term use of neuroleptics (haloperidol, chlorpromazine) about schizophrenia. Assigned oral homeopathic solution C30 solution of monoclonal antibodies to RISPERIDONE(3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl) piperidino] ethyl] -6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a] pyrimidine-4-one), 2 times a day 5 ml intramuscularly. When you re-inspection after 7 days had no tremor tendency to normalization of gait. Psychotic disorders no.

E. Patient S. , 29 years old, suffers from depressive-paranoid form of schizophrenia. For a number of years taking antipsychotics phenothiazine series, the best clinical effect was detected in DISARCINA (2-methoxy-10-(3-dimethylamino-2-methyl-propyl) - fenotiazina hydrochloride). For the last 4 months and relatives of the patient himself drew attention to the growing extrapyramidal disorders, deterioration of the activity of the intestine (constipation). Clinical blood analysis showed a reduction in blood content of up to about 1 tablet 3 times a day (due to cancellation of disarcina) for 20 days resulted in a significant reduction in extrapyramidal disorders, normalization of bowel function of leukocytes increased to 4,7103/µl. Psychotic disorders are absent. Sleep, appetite, mood - within normal limits.

F. Patient F., 19 years old, trained in the degree of idiocy, and aggressive. Receiving maintenance doses of HALOPERIDOL (4-[4-(parachlorophenyl)4-oxypiperidine] 4-verbalization) (20 mg/day). Pronounced extrapyramidal disorders. A lower dose of the drug increases aggressiveness. The use of potentiated polyclonal antibodies to butyrophenone C30 1 tablet 2 times a day improved the portability of HALOPERIDOL and allowed to gradually reduce the dose to 5 mg per day, and then to maintain the patient in a satisfactory condition using only potentiated drug.

Example 6. Potentiated antibodies to small tranquilizers

A. Patient Century, 50 years, researcher. About neurosis obsessive-compulsive disorder takes daily tranquilizer MEDAZEPAM, notes drowsiness (possibly broken /changed/ detoxification function of the liver). The use of potentiated polyclonal antibodies to the benzodiazepine core C30 allowed to replace the tranquilizer. The condition is satisfactory. Neurotic, Rastro moralnego of drug potentiated polyclonal antibodies to DIAZEPAM (7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-one) C200 1 tab. 3 times a day. After 4 days according to the observations of GP normalization of sleep, reducing complaints against anxiety.

C. Patient C. , 30 years old, registered in the mental hospital, he complained of restlessness, anxiety, insomnia, introduced after the abolition of PHENAZEPAM. Assigned oral 2 times a day homeopathic dilution of antisera to C30 2H-1,4-benzodiazepine. After two days of receiving normalization of sleep and mood. A satisfactory condition, no alarm.

D. Patient I., 39 years old, came with complaints of fatigue, incoordination, anxiety. Examination revealed no organic disorders of the Central nervous system. After a diagnosis of "neurasthenia" was proposed course of treatment homeopathic solution of polyclonal antibodies to PHENIBUT (gamma-amino-beta-phenylalkanoic acid hydrochloride) C12. After 2 days twice (during the day) administered orally 1 table. drug marked reduction of tremor, normalization of sleep.

Example 7. Potentiated antibodies to antidepressants

A. Patient Century, 36 years old, came with complaints of worsening of mood. Sleep disorders - early awakening, difficulty covered the e homeopathic solution C30 antisera to FLUOXETINE (PROZAC) (+-)-N-methyl-gamma-[4-(trifluoromethyl) phenoxy] benzoylpropionic): 5 drops 3 times per day. When you re-inspection after 5 days the patient reported improvement of mood, tendency to normalize sleep. It is recommended to continue the treatment.

C. Patient K., 39 years old, came with complaints of insomnia, tremor, anxiety, decreased performance. She was prescribed a course of oral administration of potentiated polyclonal antibodies to FLUVOXAMINE ((E)-5-methoxy-1-[4-(trifluoromethyl)phenyl] -1-pentanone-0-(2-amino-ethyl)oxime) S 1 tablet 4 times a day. After 3 days of daily intake were observed normalization of sleep, reducing anxiety, improving mood.

C. Patient W. , 56 years old, came with complaints of anxiety, fear, sleep disturbances. Recommended intranasal taking 1 ml 3 times daily 2% solution of antisera to AMITRIPTYLINE (3-(10,11-dihydro-5H-dibenz[a,d]-cyclohepten-5-ilidene)-N,N-dimethyl-1-propanamine) C30.

D. After 3 days with the re-examination the patient was noted normalization of sleep, reducing the frequency and intensity of attacks phobias. It is recommended to continue treatment with the drug, marked by its high efficiency in this case.

That is, Young man, 18 years old, suffers from childhood enuresis. A good effect was discovered in the appointment Amitripty attention to his drowsiness, the patient himself notes the deterioration of vision (disorder of accommodation), sometimes occurring arrhythmia. Applied potentiated monoclonal antibodies to tricyclic group with50, which constitutes the basis of tricyclic antidepressants, 1 tablet 2 times a day. Symptoms side effects disappeared, therapeutic effect is maintained.

F. Sick Hours, 32, Manager. Makes a large number of complaints about poor health, among which the main place is occupied by constant fatigue, bad not refreshing sleep, poor health, depression, constipation, muscle and joint pain. This state lasts for more than six months. A thorough clinical and laboratory examination revealed no neurological or somatic pathology that can cause similar syndromes. Diagnosed with "chronic fatigue Syndrome". Held during the months of combined therapy, including physical therapy, vitamin therapy, antidepressant IMIPRAMINE gave a weak positive effect. Treatment potentiated antibodies to IMIPRAMINE in breeding C200 1 tablet 3 times a day. A week later recorded a significant improvement of the patient, increased rabotosposobnost what iagnosis: "Manic-depressive psychosis in the acute stage". During the inspection noted complaints about the lack of motivation, tearfulness, the patient is not physically active. Previously a long time took amitriptyline and diazepam. Assigned oral solution antisera to MOCLOBEMIDE (aurorix) (p-chloro-N-(2-morpholinoethyl)benzamide) in 5 ml of an aqueous solution S 2 times a day. When you re-inspection after 4 days the patient contact, marked by elevated mood, improved mobility. The conclusion about the effectiveness of therapy.

N. Patient S. , 49 years. Suffers from depression and social phobia, taking MOCLOBEMIDE (aurorix) 225 mg/day (1.5 tablets for three steps). Despite the warnings of the attending physician, periodically breaking the diet. Twice after eating a sandwich with cheese and pizza (contains cheese) was observed rise in blood pressure up to 190/110 mm RT. Art. due To cancellation of moclobemide used potentiated polyclonal antibodies to moclobemide C30 1 tablet 1 time per day. Later he tolerates it well, symptoms of depression quickly degenerate.

L. The patient S., 44, against the background of menopause appeared mood swings, tearfulness, decreased vitality, assessed by the psychiatrist as a depressive syndrome. On the background of the e potentiated affinity-purified antisera to SERTRALINE in breeding C12 1 tablet 2 times a day quickly led to improvement, the mood has leveled off.

Example 8. Potentiated antibodies to antiemetic means Central action

A. patient J., 64 years, radiation therapy, and chemotherapy, held on the occasion of peripheral lung cancer, she had nausea and vomiting. The purpose of MOTILIUM reduced the effects of dyspepsia, however, began to grow weakness, drowsiness, pain appeared spastic nature in the course of bowels. Due to cancellation of MOTILIUM the purpose of potentiated antibodies to MOTILIUM C6 1 ml intramuscularly 2 times a day resulted in the disappearance of neurotoxic and spastic reactions. The drug was continued with a positive clinical effect.

Example 9. Potentiated antibodies to muscle relaxants Central action

A. Patient B., 25 years. After spinal cord injury developed contractures of the lower extremities. Assigned MIDOKALM (1-piperidino-2-methyl-3-pair-of tolylpropan-3-hydrochloride), 300 mg/day. When a good initial effect after 2 months of treatment was a gradual increase in muscle tone of the lower extremities, decreased systemic blood pressure 105/60 mm RT. Art.). The purpose of potentiated antibodies to MIDOKALMA C200 1 tablet 2 times a day resulted in us 4 times.

Example 10. Potentiated antibodies to cholinesterase inhibitors

A. the Patient P., aged 20. The diagnosis of Congenital myasthenia gravis". As the primary drug takes UPRATED (3-hydroxy-1-methylidene hexamethylene-bis-(N-methylcarbamate) dibromide) (maintenance dose is 1 tablet every other day). Began to notice increased salivation and abdominal cramping. The use of potentiated antibodies to UBRETID D6 1 tablet in the morning daily improved tolerability ubretid without reducing its effectiveness, and then allowed to go to therapy only potentiated drug.

Example 11. Potentiated antibodies to psychostimulants and nootropics

A. the Patient M, 58 years old, came with complaints of memory impairment, insomnia. The recommended oral in potency C200 antibodies to NOOTROPIL (piracetam) (2-oxo-1-pyrrolidinyl) 20 drops of alcohol solution at a dose before bedtime. When you re-visit after 7 days increased the duration of sleep, relief of sleep. It is recommended to continue the treatment.

C. the Patient M , 43, stood out in the hospital in a state of alcohol withdrawal. In a day marked by complaints of anxiety, tremor. An appointment is tocheny reduction of tremor, improvement of mood. After 2 days of therapy the patient was discharged in satisfactory condition.

C. Patient S., 72 years old, has complained of tachycardia, insomnia. History of long-term (3 weeks) deadline for SYDNOCARB (3-(alpha were)-N-phenyl-carbamoylethyl). Assigned intranasal introduction of a solution of monoclonal antibodies to SYDNOCARB 15 10 drops 3 times a day. After 5 days of reception at repeated inspection noted the absence of tachycardia, subjectively: improved sleep.

D. Century Patient, 65 years of age. Diagnosis: "Asthenic syndrome in a remote period of craniocerebral trauma". To prevent attacks of the patient accepts MOLSIDOMIN (ethyl ester of N-carboxy-3-morpholino-sydnonimine) on 1 tablet 3 times a day (6 mg/day). The doctor had complained of headache and deterioration of sleep. After the abolition of MOLSIDOMINE treatment potentiated monoclonal antibodies to the grouping of sydnonimine C30 1 tablet in the morning. The beneficial effect of the treatment lasts for 6 months.

E. Sick Days, 38 years old, came with complaints of fatigue, weakness, headache. Assigned to oral administration of potentiated polyclonal antibodies to C40 CAFFEINE pain, relief awakening. It is recommended to continue the treatment.

F. the Patient P., aged 35, a journalist. There are signs of addiction to caffeine: to maintain the health drinks per day for up to 12-15 cups of strong coffee. Emotionally unstable, prone to overestimation of their own personality, says a bad dream. Pronounced tremor of the hands. The use of potentiated antibodies to CAFFEINE (1,3,7-trimethylxanthine) C200 1 tablet 3 times a day resulted in the reduction of intake of coffee to 4-5 cups, improved sleep, normalized mood disappeared tremor. The patient is active, said a high efficiency.

G. Patient R., 78 years, in connection with Alzheimer's disease receiving regular PIRACETAM (nootropil) (2-oxo-1-pyrrolidinylcarbonyl) at a dose of 1.6 g/day. On the favourable effect of the drug relatives noticed increased sexual activity of the patient, manifested inappropriate behavior. Replacement piracetam potentiated antibodies to PIRACETAM C200 eliminate sexual disinhibition - taking save neuroprotective effect.

N. The patient Was a 4-year delay of mental development due to birth trauma. The course of injections of CEREBROLYSIN (companyveles activity of the child. When repeated courses Cerebrolysin replaced potentiated polyclonal antibodies to it (1 tablet with50 2 times a day). Significantly improved memory, increased ability to acquire and maintain skills.

Example 12. Potentiated antibodies to drugs, improves cerebral blood circulation

A. the Patient L., 54 years old, atherosclerosis of brain vessels, a month ago, suffered an ischemic stroke. Gets GALIDOR (1-benzyl-1-(3-dimethylaminopropoxy)-Cycloheptane fumarate) tablets (100 mg 2 times a day). Complains of sleep disorders and tachycardia (92 BPM). The use of potentiated antibodies to Galidor C30 (1 tablet daily for one month) improved sleep, the heart rate decreased to 76-80 beats/min

Example 13. Potentiated antibodies to analiticheskii tools

A. Patient T. , aged 15, arrived in a state of alcoholic intoxication. When viewed hypotension 90/60, bradycardia, nausea. Assigned intranasal introduction of antisera to KORDIAMIN (N,N-diethyl-3-pyridinecarboxamide) C200 at 1 ml 1 h After 6 h of admission indicated the disappearance of nausea, normalization of blood pressure.

Example 14. Potentiated antibodies to anticonvulsant (which they extremities. The recommended oral administration of calcium gluconate in combination with homeopathic solution of antibodies to DEPAKINE (SODIUM VALPROATE) (Sodium 2-propylvaleric) D12 10 ml before going to sleep. The observed decrease of convulsive reactions after 2 days of therapy.

C. Patient E., 47 years old, was admitted to hospital with exacerbation of sciatica. In complex therapy in conjunction with anti-inflammatory drugs assigned intranasal introduction monoclonal antisera C30 to FINLEPSIN (TEGRETOL) (5N-Dibenz [b,f]azepin-5-carboxamide), 10 drops of a 25% alcohol solution at the reception. In a day marked decrease hypertonicity of muscles, reducing pain.

C. So Sick, 64 years old, had complained of insomnia, convulsions of the limbs at night. In the complex therapy assigned potentiated anticavity C30 to PHENOBARBITAL (5-ethyl-5-phenyl-2,4,6(1H, 3H, 5H)-pyrimidinetrione) oral 20 ml before going to sleep. When you call after 10 days, normalization of sleep, a significant decrease in the frequency of convulsive reactions.

D. Patient I., aged 45, with a diagnosis of Epilepsy, generalized form of" forced refused to receive LAMOTRIGINE (6-(2,3-dichlorophenyl)-1,2,4-trial to LAMOTRIGINE C30 intranasal 10 drops 3 times a day helped to eliminate nausea and continue the course of treatment. Within 3 months of observation of generalized epileptic seizures not.

That is, the Patient U., 39 years old, the diagnosis of Epilepsy with rare absences", treatment PHENYTOIN (5,5-diphenyl-2,4-imidazolidinedione), he complained of dizziness, tremor. The drug is cancelled. Assigned to oral administration of potentiated antisera to phenytoin D6 20 ml 3 times a day. Already after 2 days marked improvement of health, the disappearance of tremor. Within 8 weeks of absences were noted.

F. the Patient P. , 49 years old, came with complaints of pain and tension in the calf muscles. A history of the sciatic nerve. To reduce muscle tone assigned to oral administration of 20 ml gomeopaticheskogo solution of monoclonal antibodies to BACLOFEN (beta(aminomethyl)-4-chlorobenzophenone acid) C30 3 times a day together with anti-inflammatory therapy. A repeat application after 7 days decreased muscle rigidity, reducing pain.

Example 15. Potentiated antibodies to ANTIPARKINSONISM tools

A. the Patient D., 76 years of age, diagnosed with Parkinson's disease was treated with the drug LEVODOPA (3-hydroxy-L-tyrosine). Due to the lack of effect is 1 tablet 3 times a day. Noted after 3 days the elimination of tremor. The conclusion about strengthening the effectiveness of therapy. After 3 months the patient is fully transferred to antitelomerase. A slight tremor. The condition is satisfactory.

C. Patient K., 69 years, with the diagnosis of Atherosclerosis of cerebral vessels. Parkinsonii syndrome", he complained of nausea after taking SELEGILINA (DEPRENYL) ((R)-N,alpha-dimethyl-N-2-propenylbenzene). Purpose homeopathic solution of antibodies to (R)-N, alpha-dimethyl-N-2-propenylbenzene D (intranasal, 10 drops 3 times a day) helped to eliminate nausea and continue treatment with antibodies as monotherapy.

Example 16. Potentiated antibodies to the drugs used mainly in the treatment of conditions based

A. Patient Century, 41, took place course of treatment in order to eliminate the Smoking habit. Assigned intranasal taking 20 drops of antisera to NICOTINE (S)-3-(1-methyl-2-pyrrolidinyl) pyridine) S 2 times a day. Patients noted a decrease of the attraction to Smoking after 4 days of taking the drug.

C. Patient D., 19 years old, hospitalized with suspected drug abuse. After 2 h after oral administration of 3 ml homeop is) with50 marked the development of the syndrome, what is estimated as malaconotinae effect. Further admission of potentiated antibodies in complex detoxification therapy allowed within 4 days to stop the state of abstinence.

C. Potentiated antibodies to DISULFIRAM (antabuse)

Tetraethylethylenediamine

Patient E., 56 years old, was admitted to the hospital with hypotension 80/50 mm RT. Art., nausea. History of alcohol intake on the background of the drug Esperal (DISULFIRAM, tetraethylethylenediamine). After 5 h after intranasal 2 ml of a solution of potentiated antibodies to disulfiram C30 were observed normalization of pressure, eliminate nausea. However, when conducting alcohol tests reappeared vegetative disorders.

Example 17. Potentiated antibodies to NARCOTIC ANALGESICS

A. Sick Hours , 22 years old, was admitted to our Department with symptoms of heroin withdrawal. For reducing the pain in the first hour as monotherapy twice intramuscularly introduced 1 ml of a dilution of polyclonal antisera to TRAMAL (TRANS-(+-)-2-[(dimethylamino)methyl]-1-3(-methoxyphenyl) cyclohexanol hydrochloride) with50. Pain almost stopped. Appointed traditional desint ordinan-3,14-diol)

Patient R. , 24 years old, hospitalized in narcological hospital with the diagnosis: "Opium withdrawal syndrome". History of long-term (6 months). reception of various opiates. The purpose gomeopaticheskogo solution of monoclonal antibodies to MARADALU (17-Cyclobutylmethyl) morphinan-3,14-diol) C200 30 ml orally 3 times a day reduced the intensity of pain syndrome and the severity of craving for drugs.

C. Potentiated antibodies to MORPHINE.

Patient C., 24 years old, diagnosis: "Heroin addiction, remission 7 months, complained of pain in the right TMJ. Examination revealed no organic pathology. An appointment potentiated the antisera to the Morphine D24 (1,2,5-trimethyl-4-phenyl-4-piperidinol propanoate). After a single dose was observed disappearance of pain on the background of fast transient phenomena "dry" abstinence. When interviewing notes that "passed" the craving for heroin increased 10 days ago.

D. Potentiated antibodies to MORPHINE (5-alpha, 6-alpha)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol.

Patient Z. , 29, surgery appendectomy. For the treatment of postoperative pain is Ilmarinen-3,6-diol) C30 oral, once at night. The patient fell asleep. Upon further questioning notes that with the introduction of the drug euphoria experienced.

That is Potentiated antibodies to FENTANYL (N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide)

Patient T., 68 years old, was admitted with complaints of pain in the spine. A history of bone metastases of gastric cancer in the body of the vertebrae, long-term use of narcotic analgesics. Assigned to be administered by slow intravenous solution of potentiated antibodies to N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide (FENTANYL) D 12 2 ml 2 times a day. After 4 days was observed subjective reduction of pain syndrome.

Example 18. Potentiated antibodies to the anticholinesterase means

A. Potentiated antibodies to PHYSOSTIGMINE ((3S-CIS)-1,2,3 and 8,8 and hexahydro-1.3 a,8-trimethylpyrrole[2,3-b]indol-5-ol methylcarbamate)

Patient F., 63, was observed after stroke. Objectively reduced muscle tone of the left hand. As part of a comprehensive therapy appointment of a solution of potentiated monoclonal antibodies to PHYSOSTIGMINE (3S-CIS)-1,2,3 and, 8,8-Hexahydro-1.3 a,8-trimethylpyrrole [2,3-b] indol-5-ol methylcarbamate) with50 route 3 times a day, 0.5 ml After 3 weeks of receiving normalization musicnov trimethylindolenine bromide).

Patient H. , 60, surgery appendectomy. In the postoperative period, there was paresis of the intestine. Assigned to oral administration of antisera to PROSERINE (3-[[(dimethylamino)carbonyl]-oxy] - N,N,N-trimethylindolenine bromide) C200 1 tablet 3 times a day. After 4 days of admission were observed normalization of gastrointestinal motility.

Example 19. Potentiated antibodies to protivoglaucomny tools

A. Sick Ya, 70 years. For a long time suffers from glaucoma. As an effective medication the patient is taking ACETAZOLAMIDE (250 mg every 6 hours courses of 5 days). Its action is associated with blockade of carbonic anhydrase, and in the long continuous receive compensatory mechanisms reduce the effectiveness of the drug. Therefore there was a need to periodically stop the drug. During the forced interruption attacks of glaucoma often, other protivoglaucomny drugs the patient can not tolerate. The purpose of potentiated antibodies to ACETAZOLAMIDE C6 1 tablet daily regained sensitivity to the drug, the intraocular pressure is maintained at the upper limit of normal, the incidence of seizures glaucoma decreased significantly. Acetazolamide cancelled. The follow - up period was 4 months.


Patient N., 41 years old, complained of paroxysmal pain in the left side of the head. Diagnosed with "Migraine". Assigned intranasal reception of potentiated monoclonal antibodies to DIGIDROERGOTAMINA (5-alpha, 10-alpha)-9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl) ergotaman-3,6,18-trinocular) C200 1 tablet 4 times a day. When you re-inspection after 7 days, the patient noted a decrease in the frequency and intensity of pain. It is recommended to continue the treatment.

C. Antibodies to SUMATRIPTAN (3-[2-(dimethylamino)ethyl]-N - methylindol-5-methanesulfonamide).

Patient K., 42, turned to the clinic about headaches in the left part of the head, accompanied by nausea. Recommended in conjunction with analgesics at the time of the attack by 1 ml of a solution of potentiated monoclonal antibodies to SUMATRIPTAN (3-[2-(dimethylamino)ethyl]-N-methylindol-5-methanesulfonamide) D24 oral. During the second visit the patient reported the disappearance of nausea and decrease in pain intensity.

Example 21. Potentiated antibodies to local anesthetics

A. Antibodies to LIDOCAINE ((2-diethylamino)-N-(2,6-dimetilfenil) ndimethylacetamide).

Patient R., 32 years old, came with complaints serdp oral potentiated antibodies to LIDOCAINE (2-diethylamino)-N-(2,6-dimetilfenil)ndimethylacetamide) C12 1 tablet every hour for patients normalization of heart rate.

Example 22. Potentiated antibodies to NSAIDs

A. Potentiated antibodies to DICLOFENAC (2-[(2,6-dichlorophenyl) amino] venzolasca acid

Patient M. , 52 years old, complained of knee pain. During the examination the following diagnosis: Arthritis in the acute stage and assigned compresses with homeopathic solution of antibodies to DICLOFENAC (2-[(2,6-dichlorophenyl)amino] venzolasca acid) C6. After four treatments the observed decrease redness and pain of the joints.

Century Potentiated antibodies to INDOMETHACIN

Patient D. , 48 years old, came with complaints of pain in the epigastric region. History long (1.5 months) receiving INDOMETHACIN (1-(4-chlorbenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid). When gastroscopy marked erosive gastritis. An appointment gomeopaticheskogo solution in potency C30 antisera to indomethacin 1 tablet 3 times a day. When you re-inspection after 7 days indicated the disappearance of pain.

C. Potentiated antibodies to CYCLOOXYGENASE

Patient F., 49 years old, for 12 years, suffering from rheumatoid arthritis. The use of NSAIDs all groups, even MOVALIS (a drug with a relatively izbire potentiated form of antibodies to cyclooxygenase 1 D12 - 1 tablet orally 2 times a day tolerates the purpose of Movalis. Joint pain decreased mobility was restored. Endoscopically - hyperacid gastritis in remission.

D. Potentiated antibodies to IBUPROFEN (alpha-methyl-4-(2 - methyl-propyl) venzolasca acid)

Patient L., 56 years old, came with complaints of pain and limitation of motion in the ankle joint. He was appointed oral administration of IBUPROFEN in combination with intranasal introduction of potentiated antibodies to alpha-methyl-4-(2-methylpropyl) benzooxazol acid C12 0.5 ml twice a day. After 5 days normalization mobility and no pain. Ibuprofen cancelled. Only gets potentiated antibodies. Inflammation and pain in the joints there.

Potentiated antibodies to ASPIRIN (2-(atomic charges)benzoic acid)

That is So Sick, 48 years old, came with complaints of a headache. When examining the observed increase in temperature to 37.oC. Proposed preformed drug potentiated antibodies to ASPIRIN (2-(atomic charges)benzoic acid) C30 1 tablet 4 times a day. A day after normalization of temperature and the complete absence of headache.

F the drugs ACETYLSALICYLIC ACID (325 mg 1 time per day). Complains of discomfort in the stomach, clinical analysis showed prolonged blood clotting from 5 to 12 minutes Assigned potentiated antibodies to ASPIRIN FROM 12 to 1 ml intramuscularly once a day. Discomfort in the stomach disappeared, and the coagulation time was reduced to 8 minutes

G. Potentiated antibodies to PARACETAMOL (N-(4-hydroxyphenyl)ndimethylacetamide.

Patient N., 11 years old, was admitted with a diagnosis of "Acute respiratory disease". When examination revealed a temperature of 38.2oC, rhinitis. Together with galazolin assigned oral administration of 10 ml aqueous solution of potentiated antibodies to PARACETAMOL (N-(4-Hydroxyphenyl)ndimethylacetamide) 4 times a day. After 1/2 day of normalization of temperature, reduction of rhinitis.

Example 23. Potentiated antibodies to medicines that affect the function of the respiratory system.

A. Potentiated antibodies to FENOTEROL (1-(3,5-dioksifenil)-2-(para-hydroxy-a-methyl-phenethylamine)-ethanol)

Patient K. , 22 years. Suffering from asthmatic bronchitis. As the primary drug uses FENOTEROL (Berotec) in the form of an aerosol. Notes the reliability and effectiveness of the drug, but complains of tremor cyst is ablett 2 times a day improved tolerability without compromising its effectiveness. Gradually transferred to the reception only potentiated funds. Asthmatic attacks within 5 weeks was not observed.

Potentiated antibodies to ATROVENT

C. A. Patient, 26 years old, suffers from polyallelic, including soybean and groundnut. Due to frequent attacks of bronchial asthma successfully applied ATROVENT in solution for inhalation. After a single use ATROVENT in the form of an aerosol inhalation, the patient developed a severe anaphylactic reaction. An anaphylactic reaction is eliminated by antibodies to atrovent D24 - intranasal 0.5 ml three times with an interval of 20 minutes In the future as monotherapy received potentiated antibodies to atrovent D12 1 tablet in the morning daily. Feel satisfactory. Asthmatic attacks is not within three months.

C. A. Patient , 45 years is a long time took THEOPHYLLINE about bronchial asthma attacks. The patient noted a decrease in the effectiveness of the drug. Receiving oral potentiated solution of antibodies to THEOPHYLLINE (1,3 dimethylxanthine) C30 1 tablet 2 times a day increased the effectiveness of therapy that has helped to reduce the dosage of theophylline.

D. Sick Days, 36 years. With 19 years St is in the evening, 1/3 in the morning. Complains of irritability, worsening of sleep. A lower dose of the drug on the sleep quality is not affected, but became more frequent nocturnal asthma. Treatment gomeopaticakimi antibodies to theophylline C30 1 tablet 2 times a day. Within 3 weeks of sleep was restored, the dose of theophylline reduced to 300 mg, attacks are rare.

That is Potentiated antibodies to MENTHOL (2-isopropyl-5-methylcyclohexanol-1)

Sick Hours , 39 years old, came with complaints of cough, dryness in the throat. Recommended to take the tablets drug potentiated antibodies to menthol (2-isopropyl-5-methylcyclohexanol-1) C12 during the attack. With repeated treatment, the patient noted the effectiveness of the drug to eliminate the cough. It is recommended to continue the treatment.

Potentiated antibodies to adrenomimeticescoe tools

F. Potentiated antibodies to NAPHAZOLINE (NAFAZOLINA) (4,5-dihydro-2-(1-naphthalenyl)-1H-imidazole).

Patient C. , 49, has complained of tachycardia after administration of naphazoline about rhinitis. Proposed replacement of naphazoline on oral homeopathic solution monoclinal antibodies to 4,5-dihydro-2-(1-naphthalenyl)-1H-imidazole C6 1 table the next day the start of a treatment rinorea virtually no.

G. Potentiated antibodies to SALBUTAMOL (alpha 1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzodithiol)

Patient I. , 54 years old, came complaining of attacks of shortness of breath. Assigned intranasal installation homeopathic solution of antibodies to SALBUTAMOL (alpha 1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzodithiol) with50 (5 drops of aqueous solution 3 times a day). The drug reduced the duration of episodes of respiratory disorders.

Example 24. Potentiated natical to histamine and antihistamines tools

A. Potentiated antibodies to CREMOLINO (5,5-[(2-hydroxy-1,3-propanediyl) bis(oxy)]bis[4-oxo-4H-1-benzopyran-2-carboxylic acid)

Patient M. , aged 57, was suffering from seasonal hay fever. The purpose of the drug potentiated antibodies to CREMOLINO (5,5-[(2-hydroxy-1,3-propanediyl) bis(oxy)] bis[4-oxo-4H-1-benzopyran-2-carboxylic acid) in the C30 nasal 1 ml 2 times a day helped to eliminate the symptoms of rhinitis.

Century Potentiated antibodies to ZADITEN (KETOTIFEN) (4,9-dihydro 4-(1-methyl-4-piperidinylidene-10H-benzo[4,5] cyclohepta[1,2-b] -thiophene-10-he (gidrofumarat)

Patient M. , aged 29, programmer. Suffers from hay fever with symptoms of keratoconjunctivitis in Vienna taking ZADITEN, in addition to positive therapeutic effect, caused a decrease in the intensity of emotional and physical reactions, lethargy, drowsiness. The purpose of potentiated antibodies to ZADITEN C30 1 tablet 2 times a day resulted in the disappearance of adverse reactions to ZADITEN. Zaditen cancelled. Receives only potentiated the drug. Effects of hay fever no.

C. Potentiated antibodies to TAVEGIL (1-methyl-2[2-(a-methyl-para-chlorobenzhydryl-hydroxy)-ethyl]-pyrrolidin).

Sick Hours, 35 years. For chronic urticaria repeatedly successfully took TAVEGIL. During the next exacerbation with severe skin allergic syndrome, eosinophilia in the peripheral blood of 18% parenteral use TAVEGILA (2 ml/m) resulted in rapid clinical and laboratory improvement (eosinophilia - 7%), however, appeared headache, nausea, dry mouth. The purpose of potentiated polyclonal antibodies to TAVEGIL 1-methyl-2[2-(a-methyl-para-chlorobenzhydryl-hydroxy)-ethyl] -pyrrolidin) C12 1 tablet 2 times a day resulted in the disappearance of adverse reactions to TAVEGIL. Further received TAVEGIL in combination with potentiated antibodies to TAVEGIL, and after 1 month credited only to support water pneumonia. When intravenous calcium chloride, the patient developed anaphylactic shock. Intramuscular injection of 1 ml of potentiated antibodies to HISTAMINE with50 allowed 5 min to stop shocks.

That is Potentiated antibodies to KETOTIFEN (4,9-dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophene-10-he)

Patient D., 12 years old, was admitted with complaints of shortness of breath during flowering poplar. Oral administration of 10 ml homeopathic dilution of antisera to KETOTIFEN (4,9-dihydro-4-(1-methyl-4 - piperidylidene )-10H-benzo[4,5] cyclohepta[1,2-b] thiophene-10-Oh) C24 3 times a day improved respiratory function to normal.

Potentiated antibodies to H1-receptor blockers histamine

F. Potentiated antibodies to LORATADINE (CLARITIN) (ethyl ester of 4-(8-chloro-5,6-dihydro-11N-benzo-[5,6] cyclohepta[1,2-b] pyridine-11-ilidene)-1 - piperidinecarboxylic acid)

Patient K. , aged 45, has complained of itching in the nasopharynx after working with paints. After treatment with a drug potentiated monoclonal antibodies to LORATADINE C200 (1 tablet 2 times a day) itching eliminated. The conclusion about the effectiveness of the drug.

Potentiated antibodies to TR. , 34 years old, complained of drowsiness after taking TAVEGILA, which takes the appearance of itching on his elbows. The recommended oral intake of the drug potentiated antibodies to [R-(R*,R*)]-2-[2-[1-(4-chlorophenyl)-1-phenylethane]ethyl]-1-methylpyrrolidinium D6 1 tablet 2 times a day. With repeated treatment, the patient noted eliminate sleepiness, mood enhancement. Moved to accept only potentiated drug. When you visit the doctor 2 months later notes that itch almost none.

Example 25. Potentiated antibodies to facilities for the treatment of erosive processes in the gastrointestinal tract

Potentiated antibodies to H2-receptor blockers histamine

A. Potentiated antibodies to RANITIDINE (N-[2]-[[[5-[(dimethylamino)methyl] -2-furanyl] methyl] thio]ethyl]-N-methyl-2-nitro-1,1-attentionin)

Patient N., 56 years old, came with complaints of pain in the epigastric region. An appointment after a meal and 1 tablet potentiated polyclonal antisera to RANITIDINE (N-[2]-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N-methyl-2-nitro-1,1-attentionin) C12. After 3 days of admission marked pain relief.

Century Potentiated antibodies to FAMOTIDINE(3-[[[2-[(aminoiminomethyl)nausea after eating. When gastroscopy registered gastritis in the acute stage. Recommended diet and oral 10 ml of a solution of potentiated polyclonal antibodies to FAMOTIDINE(3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio] -N-(aminosulfonyl)propanimidamide) C30 before eating. After 5 days the feeling and the picture of the gastric mucosa was normal.

Potentiated antibodies to blockers proton pump

C. Potentiated antibodies to OMEPRAZOLE (5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinil]-1H-benzimidazole)

Patient U. , 33 years old, felt a pronounced periodic pain in the epigastric region. When gastroscopy registered erosive gastritis. After the appointment of 1 tablet 3 times a day on the background diet of the preparation of polyclonal antibodies in homeopathic dilution C12 to OMEPRAZOLE (5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl] sulfinil]-1H-benzimidazole) after 6 days normalization picture mucosa, reducing the frequency and intensity of pain.

D. A. Patient, 44 years. The diagnosis of peptic Ulcer and 12 duodenal ulcer in the acute stage". Within 4 weeks of taking OMEZ (20 mg per day, blocker proton pump). Amid improving flow and antibody OMEZ D12 1 tablet 3 times a day, after 3 days side effects CNS disappeared, General condition good. In the future, was able to achieve remission by taking only potentiated antibodies to OMEZ.

Potentiated antibodies to M-holinomimeticheskie tools

That is Potentiated antibodies to PIRENZEPINE (GASTROTSEPIN) 5,11-dihydro-11-[(4-methyl-1-piperazinil)acetyl]-:H-pyrido[2,3-b][1,4]benzodiazepine-6-he

Patient P. , aged 57, has complained of tremor, epigastric pain after eating. When gastroscopy revealed no organic disorders of the mucous. The recommended oral homeopathic dilution of antisera to GASTROCHAENA (5,11-dihydro-11-[(4-methyl-1-piperazinil)acetyl]-:H-pyrido[2,3-b][1,4]benzodiazepine-6-one) D8 (1 tablet before meals). When re-examined after 10 days marked improvement in mood, pain in the epigastric region was not observed. The conclusion about the effectiveness of the drug.

F. Potentiated antibodies to ATROPINE (8-methyl-8-azabicyclo[3.2.1] Oct-3-silt ester, endo-(+-)-alpha-(hydroxymethyl) benzooxazol acid)

Patient M., 41, in 2 hours after ingestion of fatty foods experienced paroxysmal pain in the right hypochondrium. Together with the diet appointed oral rest is-(hydroxymethyl) benzooxazol acid) C200 10 ml of an aqueous solution after a meal. After 2 days marked the elimination of pain. It is recommended to continue the treatment.

G. Patient F., 42 years. Sinus bradycardia, the heart rate of 48 beats/min Takes the EXTRACT of BELLADONNA tablets. On the background of a good therapeutic effect of the extract of belladonna (pulse rate increased to 64/min) notes General weakness and dryness of the skin and mucous membranes. (Active principle extract - ATROPINE is tropinovy ester of d,l-tropovoy acid. L is the active isomer, D-isomer few active). Were assigned alternately potentiated antibodies to both isomers C15. A stable pulse - to 64 beats per minute, anticholinergic side effects, no.

N. Antibodies to SPE(Drotaverine) ([(3,4-dioxyphenyl) methylene]-6,7-diethoxy-1,2,3,4,-tetrahydroisoquinoline).

Patient L. , 38 years old, came with complaints of epigastric pain, belching. Examination revealed no organic disorders. Assigned to oral intake before meals in 15 ml potentiated aqueous solution of monoclonal antibodies to SPE(Drotaverine) [(3,4-dioxyphenyl) methylene]-6,7-diethoxy-1,2,3,4, -tetrahydroisoquinoline) C6. After 2 days of admission the patient noted a decrease in dyspepsia.

Example 26. Potentiated the antibodies is about-2-oxo-1H-benzimidazole-1-yl) propyl] -4 - piperidinyl]-1,3-dihydro-2H-benzimidazole-2-one)

Patient N. , 71, received treatment with Levodopa on Parkinson's disease. Had to stop taking due to nausea and vomiting. Was assigned to oral administration in conjunction with levodopa 30 ml aqueous solution of potentiated monoclonal antibodies to MOTILIUM(5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazole-1-yl) propyl] -4-piperidinyl] -1,3-dihydro-2H-benzimidazole-2-one) in dilution C30, thus avoiding vomiting and to continue the course antiparkinsonian therapy.

C. patient J., 64 years, radiation therapy, and chemotherapy, held on the occasion of peripheral lung cancer, she had nausea and vomiting. The purpose of MOTILIUM reduced the effects of dyspepsia, however, began to grow weakness, drowsiness, pain appeared spastic nature in the course of bowels. Due to cancellation of MOTILIUM the purpose of potentiated antibodies to MOTILIUM C6 1 ml intramuscularly 2 times a day resulted in the disappearance of neurotoxic and spastic reactions. The drug was continued with a positive clinical effect.

C. Sick Y. , 55 years. Chronic gastritis, esophagitis. Independently, under the influence of advertising for 3 months takes 10 mg for 15-20 minutes before eating MOTILIUM (active principle - Damper cancelled assigned potentiated antidiabeticheskoe antibodies DOMPERIDONE C, within 2 months, 1 tablet daily. The effects of gynecomastia disappeared, dyspepsia was not renewed.

D. Potentiated antibodies to METOCLOPRAMIDE (RAGLAN, REGLAN) (4-amino-5-chloro-N-[2-(diethylamino) ethyl]-2-methoxybenzamide)

Patient D. , 38 years old, came with complaints of nausea, belching after a meal. Was prescribed a course of oral administration of tablet preparation containing potentiated antibodies to METOCLOPRAMIDE (RAGLAN, REGLAN) (4-amino-5-chloro-N-[2-(diethylamino) ethyl] -2-methoxybenzamide) SO 2 tablets before meals. Sick 4 days noted eliminate nausea. The conclusion about the effectiveness of the drug.

Example 27. Potentiated antibodies to antitussive tools

A. Potentiated antibodies to the CODEINE ((5-alpha, 6-alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol)

Patient B. , aged 47, has complained of paroxysmal dry cough. Diagnosed with "Chronic bronchitis". Proposed intranasal administration of an aqueous solution of potentiated monoclonal antibodies to the CODEINE (5-alpha, 6 - alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-inconvenie antibodies to LIBECCIO (PRENOXDIAZINE) 1-[2-[3-(2,2-diphenylether)-1,2,4-oxadiazol-5-yl-] ethyl] piperidine).

Patient T. , 41, took pills LIBXINE about cough. Have complained of dry mouth and throat. Liexin cancelled. Proposed proally reception potentiated antisera to(1-[2-[3-(2,2-diphenylether)-1,2,4-oxadiazol-5-yl-] ethyl] piperidine in breeding with50 1 tablet 3 times a day. Purpose homeopathic remedies eliminate unwanted symptoms after 2 o'clock When viewed through two days the condition is satisfactory. Cough no.

Example 28. Potentiated antibodies to different groups of antihypertensive drugs

Potentiated antibodies to sympatholytics

A. Potentiated antibodies to RESERPINE

Patient C. , 36 years of age, was treated with adelfan about hypertension. 3 weeks later he complained of dizziness. When examination revealed a blood pressure lowering to 105/60 mm RT. senior Adelfan cancelled. Assigned oral 2 times a day 1 tablet potentiated antisera to RESERPINE C12. After 2 days, a decrease in vertigo, elevation of blood pressure to 115/70 mm RT. Art.

C. the Patient P., 72 years. Hypertension stage IIb. For a long time with good effect takes Rovaniemi. The purpose of potentiated antibodies to RESERPINE with50 reduced dizziness and eliminated a stuffy nose. In the future, within 3 months of taking the drug per 1 tablet 2 times a day. Blood pressure numbers stabilized at 140/90 mm RT. Art.

Potentiated antibodies to alpha adrenolytic

C. Potentiated antibodies to PRAZOSIN (MINIPRESS)-(1-(4-amino-6,7-dimethoxy-2-hintline)-(2-fornicator) piperazine)

Sick Hours , 53 years old, complained of a headache after taking PRAZOSIN regarding hypertension. The purpose potentiated antisera to 1-(4-amino-6,7-dimethoxy-2-hintline)-(2-fornicator) piperazine SO 1 tablet in conjunction with the drug lowered blood pressure. In the future, as monotherapy patient received only antibodies - blood pressure did not exceed the optimum for the patient of 150/90 mm RT. Art.

D. Patient I., 64 years. The diagnosis of Atherosclerosis (mainly of the lower limbs), hypertension stage IIb". Takes PRAZOSIN dose of 8 mg/day (16 tablets). Complaining of nausea and constant sleepiness. Attempt to reduce the dose has led to the rise of AD solilo to eliminate the undesirable effects and to reduce the dose of PRAZOSIN 10 mg/day. After 2 months for maintenance therapy moved to accept 1 tablet per day potentiated antibodies to prazosin with50.

That is, the Patient M, 69 years. Benign prostatic hyperplasia. Takes OMNIC (400 mg in the morning after Breakfast). The patient showed signs of orthostatic hypotension. Treatment potentiated antibodies to the OMNIC C30 1 tablet 3 times a day. After 2 days orthostatic effects have disappeared, therapeutic effect of the drug is stored, the patient's health has improved, decreased residual urine volume, frequency of urination decreased.

Potentiated antibodies to CLONIDINE (2,6-dichloro-N-2-imidazolidinylideneamino)

F. Patient E., 58 years old, came with complaints of drowsiness after taking clonidine regarding hypertension. Recommended to combine the reception of the hydrochloride with a solution of monoclonal antibodies to 2,6-dichloro-N-2-imidazolidinylideneamino C12 1 tablet 3 times a day. After 2 days of admission the patient noted improvement of mood and motor activity. Clonidine gradually abolished. Gets only antitelomerase, blood pressure stabilized.

G. Sick Y., 59 years old. In the last 10 years has essentialin the TCI. Has addressed to the doctor in the clinic with complaints of dry mouth. The appointment during the week potentiated antibodies to CLONIDINE C200 15 drops of an aqueous solution 4 times a day resulted in the removal of undesirable phenomena. For maintenance therapy was receiving only potentiated tools.

Potentiated antibodies to isomers of NEBILET

N. Patient R., 63. The diagnosis of Hypertensive disease stage IIa". Takes NEBILET (contains two isomers, both biologically active, but different people are metabolized at different speeds). Complains doctor to nightmares, to which the drug was not. Pharmacokinetic studies showed that the patient referred to a person with a slow metabolism (high difference in the plasma concentration of L - and D-enantiomers). The purpose of potentiated antibodies to L-isomer D24 1 tablet 3 times a day resulted in normalization of sleep while maintaining good hypotensive effect.

I. Patient P., 67 years old. In connection with hypertensive disease takes LABETALOL (400 mg/day). The patient complains of shortness of breath. Assigned potentiated antibodies to the RR-isomer in breeding From 15 to 10 ml twice a day orally. Across Potentiated antibodies to an inactive isomers of LABETALOL

J. A. Patient , 57 years of age. The diagnosis of Hypertensive disease, ischemic heart disease". Takes LABETALOL. Complains of shortness of breath and dizziness. Appointed a mixture of potentiated antibodies to an inactive isomers C30 1 powder daily. The condition improved, the dose was reduced from 400 mg to 50 mg/day.

K. Sick Ya , 61. The diagnosis of Hypertensive disease, ischemic heart disease". Takes APRESSIN (HYDRALAZINE) (1-Hydrazinophthalazine hydrochloride) 250 mg per day in 4 receptions. Complains of headache, flushing to the head, nausea. Reducing the dosage desired effect is not given. The patient is asked to start taking potentiated monoclonal antibodies D8 to hydrazine powered group present in the molecule apressina and is able to delay the inactivation of endogenous vasodilator factors (in particular, NO). Two days later, taking 1 tablet before meals, the patient noted improvement. Treatment apressina continued, dose reduced, while maintaining its pronounced therapeutic effect, and after 2 months apressin cancelled. The patient was transferred to only accept antibodies.

Potentiated antibodies to calcium channel blockers

Potenzirovannogo acid 3-util methyl ether

L. Sick Hours , 59 years old, took NORVASC regarding hypertension. He complained of a headache after taking it. Assigned intranasal introduction 1 ml 3 times a day potentiated antisera to 2-[(2-aminoethoxy) methyl] -4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl 5-methyl ether S 1 times a day 10 drops orally. One day headaches eliminated. Continued concomitant medications. After 6 months the patient was transferred to monotherapy potentiated drug.

Potentiated antibodies to antagonists, ACE inhibitors and angiotensin receptor 2

Potentiated antibodies to CAPTOPRIL (S)-1-(3-mercapto-2-methyl-1-oxopropyl)-L-Proline)

M. Patient L., aged 40, has complained of periodic headache, episodic increase in blood pressure. The recommended oral homeopathic solution of potentiated antibodies to CAPTOPRIL ((S)-1-(3-mercapto-2-methyl-1-oxopropyl)-L-Proline) with50 5 ml 2 times a day. Within 10 days of treatment, a marked reduction in the frequency of headaches.

Potentiated antibodies to LOSARTAN (COZAAR) (2-butyl-4-chloro-1-[[2-(1H-tetrazol-5-yl) [1,1-biphenyl]-4-yl] methyl]-1H-imidazole-5-methanol)

N. B. owano take 1 tablet 2 times a day potentiated antibodies to 2-butyl-4-chloro-1-[[2-(1H-tetrazol-5-yl) [1,1-biphenyl]-4-yl] methyl]-1H-imidazole-5-methanol D24. After 3 days of receiving tremor resolved. Further to stabilize blood pressure received only potentiated antibodies.

O. Patient E., 42 years. The diagnosis of Essential hypertension". Taking MOXONIDINE dose of 300 mg/day. Complains of dry mouth, drowsiness. Treatment potentiated antibodies to MOXONIDINE SO had a positive effect. In further translated into preventive course: 1 tablet of antibodies to moxonidine 1 time per day.

R. the Patient M, 58 years. The diagnosis of Essential hypertension IIb degree." The doctor takes ENALAPRIL 20 mg/day once. 1-[N-[S]-1-carboxy-3-phenylpropyl]-L-alanyl]-L-Proline-1-ethyl ester, an inhibitor of the angiotensin converting enzyme. Complains of cough and diarrhoea disorders. Was treated independently from dysbacteriosis, but to no avail. Bacteriological examination of the intestinal microflora revealed no pathology. Enalapril cancelled. The treatment regimen included potentiated antibodies to ENALAPRIL C200 1 tablet 1 time a day, bowel function is normalized, the cough stopped.

Q. the Patient Z. , 47 years old. The diagnosis of "Hypertension". Takes VALLARTA is siatra pathology has not revealed. The purpose of potentiated antibodies to Valsartan C30 1 tablet 2 times a day eliminated manifestations of the side effects, the dose of Valsartan reduced to 40 mg/day, and then to 20 mg/day while maintaining a stable hypotensive effect.

Potentiated antibodies to DILTIAZEM

R. Patient S., aged 54. The diagnosis of Hypertensive disease, ischemic heart disease, angina at rest". Takes DILTIAZEM 40 mg 4 times a day with good clinical effect. Angina is not more than 1 time per week. After 1.5 months of treatment began to notice ischemia heart rate (from 72 to 48-52 BPM) ECG interval extension of P-Q from 0.12 to 0.20 C. treatment potentiated polyclonal antibodies to DILTIAZEM D24 1 tablet 3 times a day. Heart rate increased to 60 beats/min, the interval P-Q decreased to 0.15, the strokes are not frequent. Dose diltiazem reduced to 20 mg 2 times a day.

Potentiated antibodies to substances that have a spasmolytic effect

Potentiated antibodies to DIBAZOL (2-(phenyl-methyl)-1H-benzimidazole)

S. Patient Z., 41, had complained of headache, nausea. Was diagnosed with "Hypertension" and recommended oral Gaza a day. When you visit 10 days marked improvement of health, the cessation of pain.

Example 29. Potentiated antibodies to substances involved in the natural regulation of blood pressure

A. Patient S. , 46 years old. For a number of years will be hospitalized for about hypertensive crises. After edema stroke translated into supportive therapy with captopril. For potentiation of hypotensive effect attached to the treatment potentiated antibodies to RENINO C12 - 1 tablet 2 times a day. Combined therapy for the first time in many years, observations have allowed to reduce the level of blood pressure to 140/100 mm RT. Art. the patient's Condition is satisfactory.

C. Patient X., 38 years. Suffering from essential hypertension resistant to therapy. The best drug for the patient is enalapril, to stabilize blood pressure readings at the level of 160/110 mm RT. senior Adherence to the treatment regimen potentiated polyclonal antibodies to ANGIOTENSINASE ENZYME D24 (15 drops of alcohol solution 3 times a day) resulted in reduced systolic pressure up to 120-130 mm RT. Art. for 2 months, no complaints.

Example 30. Potentiated antibodies to diuretics

Potentiated antibodies to FUROSEMIDE (5-(aminosulfonyl)-4-chloro-2-[(2-furylmethyl)] aminobenzoic acid.

A. Sick Days , 67 years of age, was treated with FUROSEMIDE regarding edema due to heart failure. He complained of nausea, lack of appetite. Furosemide cancelled. Recommended administration of an aqueous solution of potentiated monoclonal antibodies to 5-(aminosulfonyl)-4-chloro-2-[(2-furylmethyl)] aminobenzoic acid C30 orally 2 times a day for 20 ml. When re-inspection after 7 days marked improvement in appetite, no nausea, no edema.

Potentiated antibodies to HYPOTHIAZIDE (6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide).

C. Patient N., 64 years with a diagnosis of "Hypertension" for a long time took GIPOTIAZID (6-chloro-3,4-dihydro-2H-1,2,4 - benzothiadiazine-7-sulfonamide-1,1-dioxide). Observed a decline in the effectiveness of the drug, gipotiazid cancelled. The recommended oral administration potentiated the antisera to the hypothiazide C200 1 tablet 3 times a day, which helped to maintain diuretic effect on the background umenie antibodies to nitrate

Potentiated antibodies to NITROSORBID (1,4:3,6-Dianhydro-D-glucit the dinitrate treatment)

A. Patient W., 52 years old, suffers from hypertension, complained of a headache after the first dose NITROSORBID (1,4:3,6-dianhydro-D-glucit the dinitrate treatment). Assigned additionally, oral administration of potentiated antisera to nitrosorbid in breeding C20 (3 times a day 10 ml). After 7 days marked better portability nitrosorbid, reducing pain.

Potentiated antibodies to NITROGLYCERIN

C. the Patient U., 71. Coronary heart disease, angina. Within 5 weeks takes NITROSORBID (40 mg/day (4 tablets), and as required NITROGLYCERIN 8-10 pills a day. In the last week in connection with frequent angina attacks the number of received nitrosorbid increased to 6 tablets, nitroglycerin - 15-16 tablets. Assigned potentiated antibodies to NITROGLYCERIN C6 1 tablet 2 times a day. After 5 days, the frequency of attacks has declined, which allowed to reduce the dose as nitrosorbid to 4 tablets, and nitroglycerin - 1-2 tablets per day.

Potentiated antibodies to cytochrome a+A3

C. the Patient, A 39-year-old. Denia 4 days were treated with SODIUM NITROPRUSSIDE (Sodium nitrosalicylanilide) intravenous 100 mg/day. On day 5 the hypotensive effect of the drug significantly decreased, as in pharmacological effects of sodium Nitroprusside, a significant place is accumulated in the metabolism of sodium cyanide. (Cyanides inhibit the respiratory chain of mitochondria at the level of cytochromes a+A3). The introduction of potentiated polyclonal antibodies to CYTOCHROME a+A3 C200 1 tablet 3 times a day, restored the effectiveness of sodium nitroprusside.

Potentiated antibodies to beta-blockers

Potentiated antibodies to ATENOLOL (4-[2-hydroxy-3-[(1-methylethyl) amino] propoxy] benzoylacetone)

D. Patient E., 32, has complained of attacks of tachycardia on the background of fatigue. Electrocardiographic study revealed no organic disorders. Atenolol cancelled. Assigned to oral administration of potentiated antisera to ATENOLOL (4-[2-hydroxy-3-[(1-methylethyl) amino] propoxy] benzoylacetone) C12. The drug 2 times a day 1 tablet allowed to reduce the intensity and duration of tachycardia in 5 days after the start of treatment.

Potentiated antibodies to INDERAL (PROPRANOLOL)(1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol)

E. Patient I., 54 years old, appealed with complaints is inotherapy assigned intranasal injection of 0.5 ml of potentiated solution of monoclonal antibodies to 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol C12 2 times a day. When you re-inspection after 7 days the improvement of respiratory function. The conclusion about the effectiveness of homeopathic remedies.

F. A. Patient, 57 years of age. After myocardial infarction occurred bradyarrhythmia with bouts of Morgagni-Adams-Stokes equations. To prevent attacks takes ORTSIPRENALIN (1/2 tablet 6 times a day). Complains of nausea, dry mouth, tremor of the hands. The treatment potentiated monoclonal antibodies to JORTZIPRENALINA D3 (1 tablet 3 times a day) helped to relieve the discomfort, seizures arrhythmia was not repeated.

Potentiated antibodies to cardiac glycosides

Potentiated antibodies to DIGITOXIN ((3-beta,5-beta)-3-[(O-2,6-dideoxy-beta-D-abovecaptionskip-(1-4)-O-2,6-dideoxy-beta-D-abovecaptionskip)-(1-4)-2,6-dideoxy-beta-D-abovecaptionskip)oxy] -14-hydroxycut-20(22)-enolide)

G. Patient B. , 68 years of age, was treated with DIGITOXIN about heart failure, have complained of nausea associated with taking the drug. Assigned additional oral potentiated preparation of polyclonal antibodies (3-beta,5-beta)-3-[(0-2,6-dideoxy-beta-D-abovecaptionskip-(1-4)-O-2,6-dideoxy-beta-D-ribex day. After 2 days of admission, the patient noted the elimination of nausea. Receiving homeopathic remedies have improved the portability of digitoxin and gradually reduce the dose to 1/4 tablets 2 times a day.

N. Sick Hours, 31. The diagnosis of Chronic heart failure due to rheumatic heart disease". Taking DIGOXIN maintenance dose of 0.75 mg/day (3 tablets). Notes constant nausea, sometimes vomiting. Reduce the dose of digoxin increased the manifestations of heart failure in the first place, edema. On the background of digoxin assigned potentiated antiidiotypic antibodies to DIGOXIN in breeding D6 (1 tablet 3 times a day). Two weeks later a satisfactory condition, blood pressure stabilized, symptoms of heart failure there.

Potentiated antibodies to the complications of

Potentiated antibodies to DIZOPIRAMIDA (alpha-[2-[bis(1-methylethyl)amino]ethyl]-alpha-phenyl-2-pyridineacetic)

I. Patient S., 35 years old, came with complaints of anxiety, tachycardia. Assigned oral potentiated monoclonal antibodies to RICHILANO(DISOPYRAMIDE) (alpha-[2-[bis(1-methylethyl)amino] ethyl]-alpha-phenyl-2-pyridineacetic) Sne antibodies to RYTMONORM

J. Patient G., aged 45. In connection with ventricular extrasystoles takes RYTMONORM 150 mg 3 times a day. (propafenone-2[2-hydroxy-3-(propylamino)propoxy] -3-phenyl-propiophenone-antiarrhythmic drug With I class). When planning the study of blood found leukopenia (3,8103/ál) and thrombocytopenia (170103/µl). Rytmonorm cancelled. The use of potentiated antibodies to PROPAFENONE with50 1 tablet in the morning for 10 days normalize blood picture while maintaining the anti-arrhythmic effect.

Potentiated antibodies to SOTALOL (N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]methanesulfonamide

K. Sick Days, 28 years old, came with complaints of nocturnal disruption of heart, weak pain in left side of chest. Electrocardiographic examination revealed no organic changes of the myocardium. After the abolition of earlier therapy appointment potentiated antibodies to SOTALOL (N-[4-[1-hydroxy-2-[(1-methylethyl)amino] ethyl] phenyl] methanesulfonamide) C30 orally 1 tablet before bedtime. Over the next 10 days episodes of arrhythmia and pain is not marked.

Potentiated antibodies to VERAPAMIL (alpha-[3-[[2-(3,4-acid)ethyl]methylamino]propyl]-3,4-dimethoxy-and the DIU, the fatigue. When examining blood pressure 140/90. Recommended intake drops in the nose aqueous solution of potentiated antibodies to VERAPAMIL (alpha-[3-[[2-(3,4-acid)ethyl] methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzoylacetonitrile) C200 0.5 ml at night. Marked improvement of health, reduction of blood pressure to normal after 2 days of therapy. It is recommended to continue the treatment.

M. Patient Z., 55 years. The diagnosis of ischemic heart disease, angina, atrial premature beats, tachycardia (90 BPM)". Takes ISOPTIN 240 mg/day - 1 tablet 3 times a day. The patient complains of constipation not related to misconduct or changes in the nature of power. The purpose of potentiated antibodies to Isoptin LM 50 1 tablet 2 times a day normalize intestinal function while maintaining the main effect of isoptin. Gradually, through reducing dose isoptin cancelled. Within 2 months against the background of antitelomerase satisfactory condition.

N. Patient D., 63. Diagnosis: "Progressive chronic heart failure". In the Department of cardiology, clinical hospital treatment is carried out with MILRINONE (30 mg / day/3 times a day 10 ml). On fool in the heart. ECG signs of myocardial ischemia. Treatment potentiated antibodies to Milrinone C12 1 tablet 3 times a day. The pain disappeared, the picture ECG returned to normal, the treatment milrinone continued. The drug gradually abolished. On the background of the satisfactory condition of the patient is given 1 tablet of antibodies in the day.

O. Patient S., 58 years old, about chronic heart failure within 1.5 years takes Milrinone. During the period of taking the drug due to emergence of resistance to him daily dose increased from 10 to 30 mg. against the application of potentiated antibodies to the enzyme PHOSPHODIESTERASE C30 1 time per day 1 tablet under the tongue in the morning, the patient's condition improved markedly decreased signs of overload of the myocardium and ischemia on ECG, peripheral edema disappeared. Within 3 months of regular use of potentiated antibodies were able to reduce the daily dose of milrinone to 10 mg.

Potentiated antibodies to CORDARONE

R. Patient C., 50 years. Suffering from stable angina and paroxysmal atrial fibrillation within 2 years. With the onset of the disease takes cordarone dose of 600 mg/day (3 tablets). Through the year reported more frequent episodes of atrial fibrillation. Procarton inefficient. The paroxysms occur without communication with the emotional and physical stress, reduced spontaneously. Suspected infringement of function of a thyroid gland examined by an endocrinologist, a diagnosis of thyrotoxicosis medium. Thyroid profile: TSH - 1,29 mIU/l (N 0,45-6,2), total T4 - 180,3 nmol/l (N 39-155), T3 - 3.2 nmol/l (N 1,2-3,1). Treatment potentiated antibodies to CORDARONE C24: 1 tablet 3 times a day. During the month reached a euthyroid state, takes cordarone dose of 100 mg/day (1/4 of the table. 2 times a day), episodes of atrial fibrillation occur not more often 1 time a week.

Example 32. Potentiated antibodies to hypocholesterolemic tools

Potentiated antibodies to PROBUCOL

A. Patient K., 62. Diagnosis: "Koronarokardioskleroze, angina, hypercholesterolemia". Within 2 months, along with antianginal drugs, takes PROBUCOL (500 mg 2 times a day during meals). Complains of dyspepsia, basically, flatulence, which appeared after a month of taking the drug. The purpose of potentiated antibodies to Probucol C30 - 1 tablet a day off symptoms of bowel dysfunction. Daily dose of probucol reduced by half.

Potentiated antibodies to PRAVASTATIN

C. Patient F., 57 years. The diagnosis of coronary artery disease, the primary hypercholesterolemia". Within 3 months of taking PRAVASTATIN 20 mg at bedtime, and NITROGLYCERIN (with strokes and 5-6 tablets in day). In the last time (10-15 days) drew attention to muscle weakness. When the biochemical analysis of blood elevated transaminases up to the top of the normal values (ALT - 50 IU/l, ACT - 45 IU/l). Assigned potentiated antibodies to Pravastatin C200, 1 tablet 1 time per day, the patient's health has improved, the content values of transaminases decreased (ALT - 26 IU/l, ACT - 21 IU/l). Rarely occur angina, decreased pill burden Nitroglycerin (1-2 per day).

Potentiated antibodies to ETOFIBRATE

D. the Patient P., 55 years. The diagnosis of ischemic heart disease, Hypercholesterolemia". The doctor takes ETOFIBRATE (500 mg 1 time per day). The patient notes that after a month of taking the drug in negatives is NEWNO normalize the patient. Dose etofibrate reduced by half. Lipid metabolism in normal limits.

Potentiated antibodies to ORLISTAT

That is, the Patient O. , 59 years old. Diabetes mellitus type 2, obesity (height 160 cm, weight 100 kg). Takes inhibitor of gastric lipase ORLISTAT 120 mg 3 times a day during meals. Within months due to low calorie diet and drug the weight of the patient decreased by 7 kg, but the patient complains of feeling unwell, expressed flatulence and imperative urge to have a bowel movement. The purpose of potentiated polyclonal antibodies to Orlistat C200 1 tablet daily improved tolerability, reduced the sugar content in the blood and allowed to reduce the dose of Insulin.

Example 33. Potentiated antibodies to antitumor tools

Potentiated antibodies to DOXORUBICIN ((8S-CIS)-10-[(3 - amino-2,3,6-dideoxy-alpha-L-lysogens-pyranosyl)oxy] -7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetic)-1-methoxy-5,12-naphthacenedione)

A. Patient R., 61, underwent chemotherapy with DOXORUBICIN, (8S-CIS)-10-[(3-amino-2,3,6-dideoxy-alpha-L-oxohexanoyl)oxy] -7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-hydroxyacetic)-1-methoxy-5,12-naphthacenedione) about lung cancer. Reetika and oral solution of potentiated monoclonal antibodies to DOXORUBICIN C6. In the nausea is reduced, which allowed us to continue chemotherapy. Further doxorubicin cancelled. The patient receives only potentiated antibodies. Feel satisfactory. Radiographically: delay of tumor growth.

Potentiated antibodies to this drug called cisplatin (CIS-diaminedichloroplatinum)

C. Patient D., aged 57, while staying in a cancer hospital with ovarian cancer had complained of cramps in the lower extremities during chemotherapy with CISPLATIN. Was the medication of potentiated monoclonal antibodies to CIS-diaminedichloroplatinum C12 2 ml intramuscularly 1 time a day, which helped to arrest a convulsive reaction and to improve the tolerability of cisplatin, reduce dose in 2 times.

Potentiated antibodies to METHOTREXATE (N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid)

C. the Patient P., age 9, was admitted to the hospital with a diagnosis of Acute lymphoblastic leukemia. During initiation of chemotherapy with METHOTREXATE (N-[4-[[(2,4-diamino-6-pteridinyl)methyl] methylamino] benzoyl]-L-glutamic acid) received complaints expressed headache and nausea. Assigned to receive 1 tablet 2 times a day orally potential the headaches and decrease nausea. Accepted potentiated funds. After 2 months the patient's condition is satisfactory. Methotrexate cancelled. After 4 months on the background monotherapy antibody lymphogram close to normal.

Potentiated antibodies to THALIDOMIDE.

D. the Patient U. , 42 years. Multiple myeloma. Two bone marrow transplantation resulted in short-term remissions. After the third transplant remission was not followed, the content of myeloma immunoglobulin (MIG, protein is a marker of tumor cells) in the blood increased. In the process of treatment with THALIDOMIDE that caused lasting remission and reduction of the content of the MOMENT, the patient began to note the weakness, drowsiness, occurrence of constipation, numbness in the extremities. As an additional drug is proposed to use potentiated antibodies to Thalidomide C30 1 ml intranasally 3 times a day. After a week of using antibodies being improved, evidence of progression of the pathological process, not the content of the MIG continues to decline sharply.

Potentiated antibodies to VERAPAMIL

E. Patient W. , 29 years. The diagnosis of small cell lung cancer of the left lung". Is combination chemotherapy with cisplatin and methotrex the Alov). After a month of treatment showed signs of exacerbation. Treatment potentiated antibodies to Verapamil C200 1 tablet daily. The patient's health has improved during x-ray examinations set delay tumor growth.

Potentiated antibodies to TOPOISOMERASE II

F. Sick So, 40 years. The diagnosis of carcinoma of the lung". Conducted two courses of treatment with Cisplatin and Etoposide. Clinically and radiographically established primary drug resistance of tumors to anticancer drugs. Treatment potentiated antibodies to Topoisomerase II C30 1 tablet sublingually 1 times per day in conjunction with the third course of treatment with cytostatics. The patient's health has improved, radiographically - delay tumor growth.

Potentiated antibodies to PROSPIDINA

G. Patient R., 37 years. Is in the clinic with a diagnosis of T-lymphoma of the skin". As monochemotherapy assigned PROSPIDIN (300 mg intramuscularly 3 times a week). The reduction of skin lesions by 30% and laboratory parameters allowed to consider the treatment is effective, but further progress in patient's condition did not occur. To continue treatment additional skin decreased by 40%.

Potentiated antibodies to hormone antagonists

TAMOXIFEN((Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-imediately)

N. Patient I., aged 47, underwent chemotherapy with TAMOXIFEN (Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy] -N, N-dimethylethanamine) about breast cancer, had complained of dizziness and nausea. Assigned to 3 times a day at 0.5 ml intranasal aqueous solution of potentiated monoclonal antibodies to TAMOXIFEN C30. Decreased feeling of nausea to acceptable for the patient's intensity.

Potentiated antibodies to FLUTAMIDE (2-methyl-N[4-nitro-3-(trifluoromethyl)phenyl]propanamide)

I. Patient U. , 41, has complained of fatigue, decreased libido and potency. Assigned intranasal receiving 0.5 ml of overnight drops potentiated antisera to FLUTAMIDE (2-methyl-N[4-nitro-3-(trifluoromethyl)phenyl] propanamide) C12 1 tablet 3 times a day. Patients within 10 days of receiving the marked increase health and sexual activity. It is recommended to continue the treatment.

Example 34. Potentiated antibodies to regulators of blood coagulation

Potentiated antibodies to HEPARIN (Mucopolysaccharide ester polimernoi acid)

Potentiated antibodies to TICLOPIDINE (5-[2-Chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-C]pyridine

C. Patient K., 63, has complained of average pain intensity in the region of the heart. After the examination diagnosed with "IBS". The recommended oral administration of 20 ml overnight potentiated solution of polyclonal antibodies to TICLOPIDINE (5-[2-Chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-C] pyridine) C30 1 tablet 3 times a day. After 3 months of progression of the disease is not observed. The conclusion about the effectiveness of potentiated means for prevention of coronary heart disease.

Example 35. Potentiated antibodies to hormonal tools

Potentiated antibodies to INSULIN

A. Patient R., aged 45, diagnosed with diabetes mellitus type 1 has complained of ulcers of the skin of the lower extremities. In complex therapy of locally assigned rubbing 30% alcohol solution of antisera to insulin C30. Was observed epithelial defects of the skin.

C. Sick D., 52 years old, diagnosis: "Sachalinensis means to korrigirovat glucose cannot. Within 3 months of daily insulin dose increased from 5 to 25 UNITS. Treatment potentiated monoclonal antiadiotipiceskih antibodies to insulin C200 1 tablet daily. After 2 weeks the sensitivity to insulin increased insulin requirements decreased to 5 UNITS, the content of the fasting blood glucose 5 mmol/l After 2 months of insulin cancelled. Gets only antitelomerase.

C. Patient I., 48 years old. Suffers a severe form of diabetes, high insulin resistance (up to 128 UNITS per day). The intake of potentiated antisera to insulin-like factor C30 1 tablet 3 times a day the patient's condition improved markedly. The content of glucose in the blood decreased to 16 mmol/L. Daily dose of insulin is reduced in two times.

Potentiated antibodies to ESTRADIOL

D. Patient B. , 34 years. Was admitted to the neurology Department of the hospital with complaints in a quick violent motion in the right extremities. Symptoms occurred after colds. Rheumatism was not sick. At the time of admission second pregnancy 21-22 weeks with toxemia first half of pregnancy, first pregnancy proceeded without slnoe pressure 120/80 mm RT. senior Patient several Africa. Memory and intelligence are not affected. Detected hyperkinesis in the right extremities, mainly in the hand. Gynecologist examination: indications for termination of pregnancy no. Treatment potentiated forms of antibodies to ESTRADIOL C200 1 tablet daily after a week of phenomena hyperkinesias disappeared. Delivery on time and without complications, the baby is healthy.

Potentiated antibodies to GLUCAGON

That is So Sick , 64 years old, was admitted with complaints bradycardia, arterial hypotension. History taking atenolol. Assigned to oral administration of 1 tablet potentiated polyclonal antibodies to GLUCAGON C12 3 times a day. In a day marked normalization of heart rate and blood pressure.

Potentiated antibodies to TRIIODOTHYRONINE (LIOTIRONIN) (O-(4-hydroxy-3-with iopener)-3,5-Diod-L-tyrosine)

F. Sick Days, 36 years old, came with complaints of palpitations, pain in the heart area. When examining organic disorders are not identified. Assigned to oral administration of 1 tablet 3 times a day potentiated polyclonal antibodies to TRIIODOTHYRONINE (O-(4-Hydroxy-3-with iopener)-3,5-Diod-L-tyrosine) C12. After 5 days of admission normalization heart rythms with complaints of pain in the tubular bones and soft tissues of the extremities. After the examination diagnosed with Osteoporosis. As part of a comprehensive treatment assigned intranasal reception 2 times a day for 0.5 ml potentiated monospecific antisera to the calcitonin C24. After 3 days marked subjective decrease in pain, improvement of health.

Potentiated antibodies to GROWTH HORMONE

N. Sick Hours, 56 years old, undergoing treatment regarding obesity. The purpose orally 3 times a day 1 tablet potentiated monoclonal antibodies to growth hormone C15, together with diet allowed 10 days to reduce the weight of the patient on 4 kg, to facilitate the diet.

Potentiated antibodies to STEROID HORMONES

Potentiated antibodies to HYDROCORTISONE ((beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione

I. Patient C., age 29, occupation welder, filed a complaint with the pain in the eyes. Double introduction of eye drops containing an aqueous solution of potentiated antisera to HYDROCORTISONE (beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione) C12 allowed through the night to eliminate the pain sensation.

Potentiated antibodies to DEXAMETHASONE (11-beta,16-alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-di the ml potentiated solution of monoclonal antibodies to DEXAMETHASONE (11-beta,16-alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione) C12 itching eliminated.

Potentiated antibodies to TESTOSTERONE ((17-beta)-17-Hydroxyandrost-4-EN-3-one)

K. A. Patient , 41 years, had complained of lower potency. The examination revealed no organic disorders of the Central nervous system, marked obesity medium. Proposed course of treatment by oral administration of 1 tablet potentiated monoclonal antibodies to testosterone C6 3 times a day. When you call after 4 weeks patients noted improvement in sexual function, increased sexual activity. The patient lost 5 kg, the easier the diet in terms of appointment of the drug. It is recommended to continue the treatment.

Example 36. Potentiated antibodies to neurotransmitters of the nervous system

Potentiated antibodies to ACETYLCHOLINE (2-(atomic charges)-N,N,N-trimethylmethanaminium)

A. the Patient Y., 58 years old, came with a complaint of constipation. The recommended intake of 0.5 ml intranasal potentiated solution of antibodies to ACETYLCHOLINE (2-(atomic charges)-N,N,N-trimethylmethanaminium) with50 4 times a day. The chair was normalized through the day of drug administration.

Potentiated antibodies to NOREPINEPHRINE

C. Patient D., 71, has complained of dizziness, bradycardia. When examining the neck is the tier 10 ml. When you re-visit after 6 days being improved, dizziness patients is not checked, blood pressure 110/75. It is recommended to continue the treatment.

Potentiated antibodies to DOPAMINE

C. Patient L. , 69 years old, came with complaints tremor, gait disturbance. A history of long-term use of neuroleptics about schizophrenia. Further appointed potentiated polyclonal antibodies to dopamine C15 orally 3 times a day 1 tablet. After 4 days of admission tremor resolved, narcolepsie not.

Potentiated antibodies to SEROTONIN (5-oxitriptan)

D. Sick,, 41, has complained of worsening of mood, apathy. Offered admission in the form of drops in 1 ml 2 times a day potentiated solution of monoclonal antibodies to 5-oxitriptan (serotonin) S. After 7 days the patient noted improvement in mood, increased motivation to work. It is recommended to continue the treatment.

Potentiated antibodies to ASPARTIC ACID (L-aspartic acid)

E. Patient N., 75 years old, came with complaints tremor of the limbs. During the examination of organic lesions of the nervous system is not detected. The recommended intake for the th examination of tremor is absent.

Potentiated antibodies to GLUTAMIC ACID (L-glutamic acid)

F. Patient M., aged 29, had complained of cramps in the lower extremities during sleep. Appointment before going to sleep orally 1 tablet potentiated polyclonal antibodies to L-glutamic acid reduced the intensity and frequency of convulsive reactions.

Potentiated antibodies to GLYCINE

G. the Patient P., 58 years old, came with complaints of anxiety, sleep disorders. Assigned to oral intake before sleep 1 tablet potentiated antibodies to GLYCINE S. In 2 days ill normalization of sleep.

Example 37. Potentiated antibodies to mediators of inflammation and allergies

Potentiated antibodies to PROSTAGLANDINS

Potentiated antibodies to Misoprostol (Methyl ester(11-alpha,13TH)-(+-)-11,16-dihydroxy-methyl-9-oxoprost-13-EN-1-OIC acid).

A. Patient K. , 41, has complained of epigastric pain after eating. The recommended oral administration of potentiated solution of polyclonal antibodies to Misoprostol (Methyl ester(11-alpha,13TH)-(+-)-11,16-dihydroxy-methyl-9-oxoprost-13-EN-1-OIC acid) with50 1 tablet before meals. A repeat application after 7 d the ate to the BRADYKININ/

Patient N., 15 years old, came with complaints of dry cough. Recommended nasal drops 0.5 ml 3 times a day solution of potentiated monoclonal antibodies to bradykinin. After 2 days the cough resolved.

Potentiated antibodies to HISTAMINE (1H-Imidazol-4-ethanamine)

C. Patient T. , aged 27, has complained of severe itching caused by insect bites. In complex therapy of assigned compresses on the affected areas of skin with a solution of potentiated antibodies to histamine C30. In a day decreased redness, itching eliminated.

Example 38. Potentiated antibodies to vitamins, vitamin-like substances with action and bioflavonoids

A. A. Patient, 51 years old. On the advice of friends to promote health within two months of receiving large doses of ascorbic acid (5-6 grams a day). The clinic received in connection with an attack of renal colic. The use of antispasmodics and alkaline solutions took the painful symptoms. However, laboratory examination of blood found to have a high glucose content (9 mmol/l at norm 3,3-5,5 mmol/l). Previously the patient to endocrinologists didn't have relatives with diabetes, increasing the sugar content in the blood could be due to the toxic is elami to ascorbic acid C30 1 tablet 3 times a day. Within 2 weeks the content of fasting blood sugar decreased to 6 mmol/L.

Potentiated antibodies to THIAMINE (3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methylthiazole chloride)

Century Century Patient , 57 years old, came with complaints of pain in the left thigh. After the examination diagnosed with Neuralgia". Proposed admission potentiated solution of monoclonal antibodies to THIAMINE (3-[(4-amino-2-methyl-5-pyrimidinyl)methyl] -5-(2-hydroxyethyl)-4-methylthiazole chloride) C200 1 tablet 2 times a day. After 6 days of treatment the intensity of pain decreased. The conclusion about the effectiveness of the treatment.

Potentiated antibodies to NICOTINIC ACID (3-piridinkarbonovaya acid)

C. Patient R., 48, filed a complaint with the sensation of heat, tachycardia after administration of nicotinic acid on atherosclerosis. Recommended intake: 1 tablet 2 times a day potentiated solution of monoclonal antibodies to 3-pyridineboronic acid C30. The patient noted a decrease tachycardia, that has allowed to continue the course hypocholesterolemic therapy.

Potentiated antibodies to TROXERUTIN (2-[3,4-(bis(2-Hydroxyethoxy)phenyl] -3-[[6-O-(6-deoxy-alpha-L-manasaputras complaining of pain after injury of the hip. Upon examination revealed a large hematoma. Recommended compresses with a water solution of potentiated antisera to TROXERUTIN C6. When you re-inspection after 2 days, the size of the hematoma decreased, pain is absent.

Potentiated antibodies to DIHYDROERGOCRISTINE

E. Patient K., 29 years. In connection with the development during pregnancy and postpartum varicose veins of the legs takes RAVENOL (1 pill 3 times a day). (Includes a-adrenolytic DIHYDROERGOCRISTINE, ESCULIN and RUTOZID). On the background of decreasing swelling and a feeling of heaviness in the legs, the patient began to Lodge complaints on headache and dizziness. RAVENOL cancelled. Treatment potentiated antibodies to dihydroergocristine C30 1 tablet 2 times a day. The overall condition continues to improve, headache and dizziness disappeared. 2 months is a significant decrease in the severity of varicose phenomena.

Potentiated antibodies to the BIOFLAVONOID DETRALEX (contains a combination of Diosmin and Hesperidin)

F. Patient B. , 42, operating sister. Within 5 years suffers from varicose veins of the legs. On the recommendation of the attending physician began to take DETRALEX (on 1 tab. 2 raato treatment potentiated antibodies C30 alternately (every other day) for each component of the drug - 1 tablet per day. A significant improvement in health came after 1 week of admission antibodies. 1.5 months varicose there are no symptoms.

Potentiated antibodies to VITAMIN a (TRANS-9,13-Dimethyl-7-(1,1,5-trimethylcyclohexen-5-yl-6-nonatetraen-7,9,11,13-ol)

G. Patient K., 26 years old, came with complaints of headache, runny nose, soreness of the joints. Order immune assigned oral administration of potentiated antisera to VITAMIN a (TRANS-9,13-Dimethyl-7-(1,1,5-trimethylcyclohexen-5-yl-6-nonatetraen-7,9,11,13-ol) C200 1 tablet daily. After 3 days when you visit normalization condition of the patient.

Potentiated antibodies to VITAMIN D(ERGOCALCIFEROL) (5Z,7E,22E)-9,10-Sakerhet-5,7,10(19),22-tetraen-3-ol

N. Patient N. , 55 years old, came with complaints of pain in the hands, not related to exercise, spasms of the lower extremities. Recommended intake potentiated solution of antisera to VITAMIN D(ERGOCALCIFEROL) (5Z,7E,22E)-9,10-Sakerhet-5,7,10(19),22-tetraen-3-Olu C200 1 tablet 2 times a day together with calcium. After 3 weeks of therapy, the observed decrease pain, disappearance of convulsive reactions. It is recommended to continue the course Leche is-1-benzopyran-ol acetate)

I. A. Patient, 43 years old, complained of fatigue, muscle weakness. After a week-long course of treatment potentiated monoclonal antibodies to VITAMIN E 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethylacetyl)-2H-1-benzopyran-ol acetate) C30 1 tablet 3 times a day to patients marked increase efficiency, improve mood.

Example 39. Potentiated antibodies to immunomodulators and cytokines

Potentiated antibodies to INTERFERON

A. the Patient P., 34, has complained of rhinitis, pain in the nasopharynx. Diagnosed with "SARS". Twice intranasal drops potentiated aqueous solution of monoclonal antibodies to gamma interferon C12 normalize the patient after 2 days. The conclusion is made that the antiviral activity of antibodies.

Potentiated antibodies to interleukins

Potentiated antibodies to ALDESLEUKIN (INTERLEUKIN 2)

C. the Patient M, 42, took place treatment in occasion of exacerbation of chronic bronchitis. The oral administration of 1 tablet 3 times a day potentiated monoclonal antibodies to interleukin 2 C30 led to a normalization of body temperature after 3 days after you start taking homeow exacerbations of chronic bronchitis no. The conclusion is made about immunostimuliruyushhim the action of antibodies.

Potentiated antibodies to COLONY-stimulating FACTORS

C. Patient L., 23, has complained of dizziness. History of long-term (20 days) admission baralgina containing a pyrazolone derivative, a dampening blood. Recommended to take orally 1 tablet 3 times a day potentiated polyclonal antibodies to FILGRASTIM (COLONY stimulating FACTOR) C200, which allowed us to normalize the number of neutrophils and red blood cells 6 days after the start of treatment. The patient's health is satisfactory. Conclusion: antibodies possess hematopoietic effect.

Potentiated antibodies to LEVAMISOLE (S)-2,3,5,6-Tetrahydro-5-phenylimidazo[2,1-b]thiazole

D. Patient K. , 41 years old, hospitalized with a diagnosis of Sinusitis". The purpose of potentiated monoclonal antibodies to LEVAMISOLE ((S)-2,3,5,6-Tetrahydro-5-phenylimidazo[2,1-b] thiazole) C12 in the form of nose drops 0.5 ml 2 times a day allowed after 3 days to fix a headache, to normalize the body temperature. The results of treatment due to an immunostimulating effect of potentiated antibodies.

That is, the Patient P., 53. The diagnosis of Hypertension II with tentunya drugs took DIBAZOL. Suggested to start the treatment potentiated polyclonal antibodies to Dibazol C30 1 tablet 2 times a day. After three days the blood pressure of 150/80 mm RT. Art. Treatment with antibodies continued. Despite the flu epidemic in the city and illness all household members, phenomena SARS patient has not arisen. The conclusion hypotensive and immunostimuliruyushhim the effect of antibodies.

Potentiated antibodies to immunosuppressants

F. Patient D., aged 27, has complained of itching and redness of the hands after working with a synthetic detergent. Diagnosed as "Allergic dermatitis". Oral homeopathic solution of monoclonal antibodies to CYCLOSPORINE C200 1 tablet 2 times a day a day reduced the severity of allergic reactions.

G. A. Patient, 28 years. Is the clinic about rheumatoid arthritis, refractory to standard Antirheumatic drugs. Within 4 months the patient were treated with CYCLOSPORINE A (CSA) with good therapeutic effect (2.5 mg/kg per day). With routine blood tests found elevated levels of creatinine, in the last week increased blood pressure (160/90 mm RT. article). The danger both to 1.5 mg/kg per day, assigned potentiated antibodies to CSA C200 1 tablet 2 times a day. A week later, the content of creatinine in normal limits, blood pressure 120/75 mm RT. Art., sustainable Antirheumatic effect of CSA is saved by his good tolerability. In the future Arc cancelled. Assigned daily intake of potentiated antibodies to 1 tablet. The follow-up period 6 months: rheumatoid arthritis in remission.

N. Patient L., 47 years old, came with complaints of pain in the lumbar region. After a diagnosis of "sciatica" in combination with anti-inflammatory drugs assigned oral polyclonal antibodies to chondroitin sulfate C12 1 tablet 3 times a day. After 2 days marked reduction of pain syndrome. Monotherapy antibodies within 7 days helped to arrest the phenomenon radiculopathy.

I. Patient O., 40 years. Participated in the liquidation of consequences of the catastrophe at Chernobyl. Radiation cataracts in both eyes. With good effect treated by ISOPENTANOL (2 drops in both eyes 5 times a day). The treating ophthalmologist has complained of itching and burning in the eyelids. The patient offered to waive drug treatment potentiated antiromance antibodies successfully continued.

Example 40. Potentiated antibodies to antibiotics and antiparasitic preparations

Potentiated antibodies to CIPROFLOXACIN (1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinil)-3-quinoline-carboxylic acid)

A. the Patient C. , 26 years old, came with complaints of cough, pain in the nasopharynx. When examining the body temperature 37,1oC. After 2 days of taking the drops of a solution of potentiated antibodies to CIPROFLOXACIN (1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinil)-3-quinoline-carboxylic acid), C12 intranasal 10 drops 3 times a day normalization of wellbeing, reduce the temperature to 36,7oC.

Potentiated antibodies to METRONIDAZOLE (2-methyl-5-nitro-1H-imidazole-1-ethanol)

C. A. Patient , 32 years old, complained of nausea after taking metronidazole. The purpose of additionally potentiated monoclonal antibodies to 2-methyl-5-nitro-1H-imidazole-1-ethanol C12 1 tablet 3 times a day helped to eliminate nausea and continue the course of treatment.

C. Potentiated antibodies to CEFEPIME([[7-[[(2-Amino-4 - thiazolyl)(methoxyimino)acetyl] amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4,2,0] Oct-2-EN-3-yl]methyl]-1-methylpyrrolidine hydroxide)

Patient E. , 36 years old, about the ligature with concomitant peptic ulcer 12 duodenal ulcer anti-inflammatory drugs were not prescribed. The recommended intake in the form of drops of a solution of C12 antisera to the antibiotic CEFEPIME([[7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl] amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4,2,0]Oct-2-EN-3-yl]methyl]-1-methylpyrrolidine hydroxide) D 1 tablet 3 times a day. After 5 days marked subsidence of the inflammatory reaction, angina eliminated.

D. Patient J., 33 years. In proctological Department of the clinical hospital sent with the diagnosis of Perianal abscess In the complex of therapeutic measures receives AMOXICLAV (on 1 tab. 3 times a day). Previously independently and randomly took different antibiotics, including dentists. (Combination of semi-synthetic penicillin Amoxicillin and b-lactamase inhibitor is Clavulanic acid). Against the background of improvement of the General condition (temperature reduction, pain reduction, decreased leukocytosis) patient complains of nausea. On the recommendation of the physician, the patient began to take AMOXICLAV simultaneously with food, but the nausea has not disappeared. Completed the treatment potentiated antibodies to 6-aminopenicillanic acid (penicillins) C6 1 tablet 3 times a day for 7 days. Tolerability was improved, no complaints, showing the observation of doctor-patient clinics, recommendations for treatment and treatment.

E. Patient Century , 34 years. Diagnosis: Bilateral polysegmental pneumonia, severe respiratory failure (NAM II-III), chronic alcoholism, chronic hepatitis, secondary immunodeficiency." Patient assigned MAXIMIM (IV Cephalosporins generation of 1.0 V/m over 12 hours). On the 3rd day of treatment the improvement of the patient. Decreased dyspnea and cough, decreased temperature. However, there are complaints of nausea, functional tests of the liver - ALT, ACT raised. In the complex of therapeutic measures included potentiated antibodies to MAXIMIMU with50 1 tablet 3 times a day. The patient's condition continues to improve, nausea disappeared, indicators ALT ACT fell to the upper limit of normal.

F. Patient K., 46 years old. In connection with acute prostatitis takes RULED (150 mg, 2 times a day). After 3 days the symptoms of prostatitis decreased, but the patient complains of dizziness, altered taste and smell of the food. Treatment potentiated antibodies to RULIDE C30 1 tablet 3 times a day, after 3 days the perception of taste and smells normalized, dizziness disappeared.

G. Patient, 25 years. Diagnosis: Exacerbation of chronic adnexitis after criminal the C 6 days on the background of improvement of the General condition of the patient appeared fainting, the patient complains of hot flashes. Assigned potentiated antibodies to CIPROBAY C200 1 tablet 2 times a day. After 3 days these complaints disappeared. The condition is satisfactory.

N. Patient W. , 44, regarding exacerbation of chronic suppurative obstructive bronchitis in accordance with the results of antibiogram were treated with CIPROFLOXACIN, has repeatedly and successfully used for a given patient. After 2 weeks of treatment clinical and bronchologically dynamics were noted. Due to cancellation of antibiotic treatment potentiated monoclonal antibodies to CIPROFLOXACIN C6 1 tablet 2 times a day. After 10 days completely disappeared phenomenon of bronchoobstructive, bronchoscopy purulent sputum was not determined. The conclusion: potentiated antibodies have antibacterial and anti-inflammatory action.

I. Patient I., 42 years old, was treated at the clinic of tuberculosis diagnosed with Infiltrative tuberculosis of the upper lobe of the right lung in the phase of decay and contamination, Bq+". For 3 months of treatment with isoniazid, rifampicin, streptomycin was obtained clinical and radiographic dynamics. In the next 2 months on fongo light remained without further reduced, patients remained. At the initial stage of the survey and after 5 months of treatment of antibiotic resistance in vitro is not detected. Treatment potentiated antibodies to ISONIAZID, RIFAMPICIN and STREPTOMYCIN C200 1 tablet of each drug every day, after 2 months have been positive rentgenologicsky dynamics, the bacteria stopped.

J. Sick Hours, 36 years. In the clinic of infectious diseases is due to amoebic dysentery. Assigned ORNIDAZOLE (1.0 per day). After 4 days of treatment the patient notes drowsiness and dizziness. Further appointed potentiated antibodies to ORNIDAZOLE C12 1 tablet 2 times a day. During the next 4 days adverse events disappeared.

Example 41. Potentiated antibodies to chelating agents

A. Sick Days, 44 years. Is in hospital Oncology center for cancer breast cancer stage III. Undergoing treatment by Doxorubicinol (75 mg 1 every 3 weeks). For the prevention of cardiomyopathy for 30 min before administration of cytostatic patient intravenous CARDIOXANE. With satisfactory tolerability Doxirubicin amid CARDIOXANE marked decrease in hemoglobin (70 g/l). the. the next three months achieved and maintained remission of the underlying disease, symptoms of heart failure does not occur, the hemoglobin content 95-100 g/L.

Example 42. Potentiated antibodies to protivopodagricakih tools

A. Patient X. , 49 years. The diagnosis of Hypertension, chronic gout". In connection with the administration of diuretics (Gipotiazid) for the treatment of hypertension as a means of preventing the aggravation of gout is taking PROBENECID (1,5 day). Complains of nausea, weakness, tenderness of the gums. Treatment potentiated antibodies to PROBENECID C12 1 tablet 2 times a day, 3 days feel better, treatment Hypothiazide and Probenecid continues (dose of Probenecid reduced in 2 times, while maintaining clinical effect).

Century Century Patient, 51 years old. In connection with chronic diarrhea not associated with an infectious process (possibly chronic poisoning by salts of heavy metals), the doctor takes IMODIUM (LOPERAMIDE). Noting the positive effect of the drug, the patient complains of dizziness. Treatment potentiated antibodies to piperidinol grouping of Imodium with50 1 S="ptx2">

Example 43. Potentiated antibodies to autologous antigens

Potentiated antibodies to antigens of DNA

Patient P., 24 years. Clinical diagnosis of Systemic lupus erythematosus with renal disease (glomerulonephritis nephrotic type) and the heart (myocarditis), subacute period, activity III degree". Taking prednisolone (50 mg/day) and the chimes (200 mg/day). In connection with the reduction of the effect of prednisolone assigned potentiated polyclonal antibodies to native DNA isolated from peripheral blood lymphocytes of the patient. Antibodies obtained by immunization of a rabbit with the subsequent purification of antisera and potentiation by homeopathic technology. The intake of potentiated antibodies to autoantigens DNA S 1 tablet 2 times a day for 2 weeks marked marked reduction in the activity of the autoimmune process. Laboratory data: a decrease in sedimentation rate from 50 to 16 mm/h, lower titers of antinuclear factor. The follow-up after 6 months of receiving potentiated antibodies: clinical and laboratory remission.

Example 44. Potentiated antibodies to the RH factor

Patient S. , 28, Rh-(male Rh+). The diagnosis of Pregnancy 8 weeks". History: this fourth pregnancy MF is ibell fetus at 38 weeks due to rhesus-conflict. For the prevention of rhesus-conflict and save this pregnancy appointed potentiated polyclonal antibodies to the RH factor C200 - 8 weeks on 1 tablet 2 times a week. The follow-up period: during therapy pregnancy was uneventful, ended urgent delivery. Child (RH-positive) healthy signs of hemolytic disease of the no.

Example 45. Potentiated antibodies to substances causing intoxication and/or dependence

Potentiated antibodies to opiates

A. Patient S. , 28 years. Within 5 years with small breaks administers intravenous handicraft prepared acetylated opium ("Saltigo"). Enrolled in drug treatment compartment through the day after the last injection. Irritable. Sullen. Notes severe pains in the limbs, chills, insomnia. Appointed: 10 drops orally potentiated aqueous solution of natural antibodies to morphine hydrochloride C200 - every 15-30 minutes Antibodies isolated from the serum of a patient with chronic marvinney dependence method of affinity chromatography. During therapy quickly disappeared vegetative disorders, decreased the incidence of myalgias. After 6 h of treatment, the patient fell asleep. After 2 days of phenomena abstine the

C. Patient K., 21 years. Enrolled in substance abuse Department with typical symptoms of opium withdrawal. When interviewing it is established that within two years receives intravenous handicraft prepared infusion of poppy straw (koknar). Assigned to combined therapy: potentiated monoclonal antibodies S to morphine - 1 tablet 1 time per 2 hours together with potentiated antibodies to the codeine C200 - 1 tablet in the morning and before bedtime. Within 48 h of abstinence phenomena controlled completely.

C. Patient I., 42 years. Was admitted to the Department of narcology by ambulance with a diagnosis of Overdose of codeine". Is somnolencia. The patient occasionally nausea. At the examination: reflexes decreased, bradycardia, mild hypotension. Intravenous slowly entered isotonic solution in an amount of 200 ml containing potentiated polyclonal antibodies to opiates fenomenologia number in the following proportions: to morphine 1 ml C200; to the codeine - 1 ml S, thebaine - 1 with50 ml; pseudomorphine 1 ml C30, neopina 1 ml C12. Within two hours after the start of therapy the symptoms of intoxication controlled completely.

D. the Patient D., age 16. Within 1.5 months not less than three times per week enters from 2 days after receipt became irritable, disturbed sleep. When the conversation notes that appeared craving for the drug. Appointed: potentiated polyclonal antibodies to heroin S - 1 tablet 6 times a day. After 3 weeks marked smooth mood, good appetite and sleep. During individual lessons with psychomotor assures that desire does not feel. It is recommended to continue to make antibodies to heroin daily 1 tablet. 2 months after discharge from hospital, according to his mother, drugs are not accepted.

E. Patient X., 24 years. Within 3 years receives intravenous handicraft cooked heroin. Was admitted to the Department of narcology able spoor. Due to the ineffectiveness of the previous intake of potentiated antibodies to heroin patient oral assigned to a mixture of aqueous solutions of monoclonal antibodies to the following synthetic and semi-synthetic opiates: dinino (Ethylmorphine) with50, to the morphine S, fentanyl C30. After 30 min, the mind clear, focused in place. Reflexes moderately reduced. Told the doctors that the disco was injected intravenously drug of unknown composition.

Potentiated antibodies to barbiturates and other sleeping tools

F. Patient B., 32 years. Polecenie recent years oral and intravenous accepts a variety of drugs from the group of barbiturates. Prescribed intravenously at 1 ml the following potentiated monoclonal antibodies to barbiturates: Barbelo (amytal sodium) with50, Nembutal (eleminal-sodium) C200, Pandora (cyclobarbital) S. Within 15 min after the start of therapy apistatus docked. The patient is in a state of clouded. In the future, when observing in the Department the patient was annoyed, was periodically observed insomnia, dysphoria. Tried to get sleeping pills. Since when interviewing, it was found that in addition to barbiturates patient takes the drugs from the group resides (bromural), and earlier and noxian, was assigned to the following treatment: potentiated monoclonal antibodies to bromural with50 together with potentiated polyclonal antibodies to nocciano C200 - every 2 h 1 tablet, alternate. Within 3 weeks the patient's condition improved markedly: dysphoria no less torpedo, normalized sleep. Stopped looking hypnotics. Was discharged in good condition.

Potentiated antibodies to cannabinoids

G. Patient S., 24 years old, was admitted to a psychiatric ward with severe depressive disorders. History of long - term use of cannabis (up to 5-8 cigars is GDI a day 10 ml of an aqueous solution, containing the following mixture of potentiated polyclonal antibodies to cannabinoids: cannabidiol with50, cannabinol C30, (- )- TRANS-9-tetrahydrocannabinol C200. On treatment for 10 days background mood has leveled off, sleep is normalized. 2 weeks after initiation of therapy with antibodies the patient was discharged in satisfactory condition.

N. Patient D., aged 14. According to his mother uses drugs within 6 months. Chewing the so-called "Bang" (the resin of cannabis). Wants to be treated. A district psychiatrist assigned potentiated monoclonal antibodies to cannabinoids: in the first 2 weeks month 1 tablet in the morning daily potentiated monoclonal antibodies8-tetrahydrocannabinol with50, the next 2 weeks by the same pattern - potentiated monoclonal antibodies 9-tetrahydrocannabinolic acid. Observation for 6 months showed that the patient refused the drug. Learns. Socially adapted.

Potentiated antibodies to cocaine and its metabolites

1. Patient S., 28 years. Within 1.5 years, uses a mixture of cocaine with baking soda "crack". He entered the medical Department with a diagnosis of Cachexia. Chronic hepatitis n is nisene asthenic phenomena to therapy added tablets potentiated monoclonal antibodies to cocaine with50 (1 tablet 2 times a day). After 3 weeks, the drug is replaced by tablets containing polyclonal antibodies to the metabolites of cocaine to benzoylecgonine with50 and Ecgonine C200. During the treatment the patient returned to normal mood, sleep, weight gain was +18 kg was Discharged in good condition after 2 months.

J. Patient O., age 17. Delivered in closed addiction unit parents. In the last 2 months has taken a solution of cocaine intravenously. When interviewing a psychologist showed signs of psychological dependence to the specified drug. Appointed: during the first 10 days of hospital stay 1 tablet 3 times a day polyclonal antibody metabolite of cocaine - norcocaine with50. Following the same pattern in the second 10 days of polyclonal antibodies to methylecgonine C200, in the third decade - polyclonal antibodies to hydroxyamino S. On the background of therapy with antibodies to the metabolites of cocaine in homeopathic doses, the patient's condition improved markedly: lined background mood, improved sleep. At discharge, 1 month for testing signs of psychological dependence is not revealed. Continued for 4 months: socially adapted. Drug addiction is not seen.

Potential is mi and psychotropic drugs benzodiazepine series. On a background of abuse has developed psychoorganic syndrome with a prevalence of astheno-apathetic symptoms, decorated group II disability. As nootropics health visitor or doctor long was appointed potentiated polyclonal antibodies to a number of benzodiazepines: chlordiazepoxide with50, diazepam with50, oxazepam C200, nitrazepama C200, lorazepam S. In the most optimal for the patient appeared to be potentiated polyclonal antibodies to clonazepam S. Takes them daily 1 tablet 2 times a day for 14 months. On the background of therapy increased intellectual and mnestic abilities. The patient ordered. Serves themselves. According to his mother no sedatives in this period was not used.

Potentiated antibodies to fenilalkilaminov and other stimulants

L. Patient S., aged 26. Was admitted to a psychiatric unit with a diagnosis of Epernay psychosis". In symptomatology is dominated by the suspense, suspicion, paranoid perception. Appointed: potentiated monoclonal antibodies to ephedrone with50 - intravenously at 1 ml twice within the first hour. After 1.5 h of treatment of psychotic disorders no. Critical p is e long (about 18 h) somnolencia. According to the wife it became known that occasionally alone was injected intravenously some stimulants, but not cocaine. Appointed: slow intravenous saline solution containing 1 ml of potentiated polyclonal antibodies to amphetamine with50 and 1 ml polyclonally potentiated antibodies to methamphetamine C30. After 15 min lethargic phenomena cropped. Clear consciousness. Is oriented correctly. Told the doctor that in the last days introduced once intravenous amphetamine.

N. Patient So , 17 years. In the last month for the first time in my life three times intravenously injected ephedrine. Independently turned to the psychiatrist, as he was afraid to become addicted. Appointed: 1 tablet 2 times a day complex preparation containing polyclonal antibodies to ephedrine and polyclonal antibodies to norephedrine in potentiated form (breeding with50 and C200, respectively). Within half a year 2 times a month visiting a doctor. According to the patient, episodes use ephedrine during this period was not.

O. Patient L., 25 years. Turned to the psychiatrist yourself. During the 1.5 years he was in prison. Addicted to cefiro. Uses last at least 1-2 times a day. Appointed: potentiated polyclo the notes, that takes cifir extremely rare - no more than 1 time a week, but to completely abandon its acceptance cannot.

Potentiated antibodies to hallucinogens (psychedelic means)

R. Patient K. , 28 years. He enrolled in the psychiatric ward of the hotel, where drew the attention of staff inadequate behavior: beheld, stopped badly oriented in the world. On the question of the doctor reported that it had taken under the tongue impregnated with the drug LSD "blotter". Appointed: once intramuscularly 1 ml of a solution containing potentiated polyclonal antibodies to lysergic acid diethylamide (LSD) C200. After 15 min after administration of psychotic disorders cropped.

Q. In a psychiatric ward delivered two brothers, A., 16, and 19 years with a diagnosis of Poisoning dried ink mushrooms". In the absence of the Department a sufficient number of potentiated funds, one of the patients intravenously introduced 1 ml of potentiated polyclonal antibodies to psilocin C200 and the other 1 ml of potentiated polyclonal antibodies to psilocybin with50. Within hours the condition of both patients returned to normal, disappeared agitation, disinhibition. Patients fell asleep. Made nevrologicheskoe Department with symptoms of catalepsy. In connection with what was known about the abuse patient drug PCP assigned: intramuscularly hourly 1 ml of a solution of potentiated antibodies to phencyclidine (PCP) D3. After 3 h cataleptic syndrome was fully docked.

S. A. Patient, 38 years. Suffers from paranoid schizophrenia. Disability group II. For 15 years, is taking large daily doses of haloperidol for the prevention of narcolepsie - parkopan or trihexyphenidyl, to which the patient has developed a physical dependence. Your doctor dose of trihexyphenidyl gradually reduced and then completely replaced potentiated polyclonal antibodies to trihexyphenidyl C30 - 1 tablet morning and night daily. The patient continues to take haloperidol. Neuroleptic effects no. Requests to assign trihexyphenidyl does not show.

Potentiated antibodies to tobacco alkaloids

So Sick And. , 29 years. Turned to the psychiatrist about tobacco use. As accepted previously neuropharmacological tools are not brought deliverance from bad habits, appointed: potentiated anticavity to nicotine C200 - 1 tablet 3 times a day. The follow-up after 3 months: during the first weeks of antitelomerase attraction priloscec cigarettes, the patient was able to stop Smoking tobacco.

Potentiated antibodies to the spirits

U. Patient B., aged 35, arrived in narcological hospital with severe symptoms of alcohol withdrawal. Assigned potentiated monoclonal antibodies to ethanol C200 1 tablet sublingually every 15 minutes On therapy for 2 h condition has improved markedly, disappeared tremor, sweating, weakness; the patient fell asleep. After 24 h was discharged in satisfactory condition. Conclusion: potentiated antibodies to ethanol have a therapeutic effect with alcohol withdrawal syndrome.

Example 46. Potentiated antibodies to fetal and primordial tissues and tissue culture

A. A. Patient , a newborn. Age - 27 days. Born with signs of perinatal encephalopathy. Due to the fact that the mother before pregnancy during immunoassay diagnosis was found to increase embryo tropic neurospecific antigens appointed: potentiated polyclonal anticavity to bovine fetal meshoperations vidospecificskie protein (antigen) 14-3-2 (meshoperations enolase) C200 - 5 drops of an aqueous solution orally 3 times a day. On the background of treatment is automaticity, decreased muscle hypertonicity. The child became calmer, actively sucking. The conclusion is that potentiated antibodies to the specified fetal antigen controlling the normal morphogenesis of the Central nervous system, effective in the treatment of perinatal encephalopathy.

C. Patient D., 4 years. The diagnosis of "mental retardation". To correct the intellectual gap appointed: potentiated monoclonal antibodies to primordial antigen nestin - protein marker of neuronal stem cells in breeding S 5 drops of an aqueous solution once in the morning for 6 months. After 6 months of neuropsychological survey found that intellectual-mnestic abilities Etc. correspond to the age, the child, with the words of the teacher of a kindergarten, a fast learner and learns the material of the workshops.

C. Patient I. , aged 8. The Diagnosis Of Down Syndrome". With the goal of therapy according to the following scheme assigned potentiated polyclonal antibodies to alpha-fetoprotein C200, within the first 12 months 1 tablet every day, following 6 months - 1 tablet 1 time in 3 days. 1.5 years during neuropsychological studies according to the method of Bailey viewliner. Diagnosis: the Male of unknown origin". Due to the ineffectiveness of traditional therapy, its background is assigned potentiated polyclonal antibodies to cultured human neuronal stem cell line of Tag-1-enriched protein extracts from embryonic tissue, in dilution C30 - 1 ml orally 3 times a day for 6 months. During therapy, increased exercise tolerance, decreased bulbar disturbances, diplopia, ptosis, which reduced several times daily doses of corticosteroids.

That is, the Patient M, 42 years. Diagnosis: Astenonevrotichesky syndrome in long-term period of tick-borne encephalitis". Due to the ineffectiveness of therapy assigned potentiated polyclonal antibodies to embryonic neocortex C200 (anticavity obtained by immunization of rabbits areas of the occipital cortex of 15-day-old embryos of Wistar rats) - 1 ml orally every day, 2 times a day for 6 months. During treatment the patient has decreased the severity of fatigue, restore the ability to work in neurological status remains "soft" signs scattered.

F. Patient K., aged 39. The diagnosis of Chronic alcoholism Art. II" On PRAMAC old did not give significant effect. Appointed: potentiated polyclonal antibodies to the homogenate embryonic hippocampus of Wistar rats (for immunization was used hippocampi several tens of syngeneic Famusov) S - 1 tablet 1 time per day for permanent admission. After 8 months of follow-up is in remission, episodes of drinking was not; notes the absence of craving for alcohol.

G. A. Patient, 8 years. The diagnosis of liver Cirrhosis of unknown etiology". In addition to therapy, not giving any meaningful effect, added: potentiated polyclonal antibodies to liver homogenate fetal human C4 - 1 ml 3 times a day orally. Within four months of therapy observed clinical improvement: reduction of symptoms of intoxication and liver failure. Increased emotional tone, gone pale skin, subikterichnost sclera, vascular "asterisks", decreased the size of the liver. The conclusion about the high efficiency of the treatment.

Example 47. Potentiated antibodies to tissues or tissue culture

A. the Patient O., age 8. The diagnosis of Insulin-dependent diabetes mellitus. Malignant course". With therapeutic purposes assigned to: rabbits with50 - 1 ml 3 times a day route. On the background of 3 months of treatment was to stabilize the disease, lowering blood glucose levels in the blood, reducing the tendency to ketoacidosis. During the period of treatment was not observed ohms and hypoglycemic conditions, the quantity of insulin is reduced in 2 times.

C. the Patient P., aged 35. The diagnosis of Insulin-dependent diabetes mellitus. Easy flow". Due to the unwillingness of the patient to receive insulin appointed: polyclonal potentiated anticavity to pancreatic islets newborn calf with50 - 1 ml of an aqueous solution orally 1 time a day. On the background of monotherapy specified drug the patient feels well. The level of glucose in the blood exceeds the norm. Insulin does not receive.

C. Century Patient, 56 years of age. The diagnosis of Stenosing atherosclerosis of the coronary arteries, angina at rest". Due to the ineffectiveness of traditional therapy appointed: potentiated polyclonal antibodies to heart homogenate newborn rabbit C30 - 3 drops of an aqueous solution route 5 times a day. On the background of the 6-month therapy decreased the intensity of the pain syndrome that occurs much less frequently than before, and only at sufficiently expressed alnum nitrates.

Thus, the analysis of the above examples shows that activated forms of ultra-low doses of antibodies to antigen - substance or medicinal product does not have a known immunological effect of binding and inhibition activity of the antigen, but instead reproduce the activity of the antigen in a modified form, which leads to a complete or partial reduction of the pathological syndrome in the regulation of the mechanisms of formation which involved the antigen. There is not specific to this antigen side effects, such as toxicity, addiction and habituation (tolerance).

In addition, activated antibodies in midget doses potentiate (increase) the effect of antigen (drug) at their joint, or a combination of the introduction into the body, which helps to reduce the dose of the drug and reduce the severity of its side effects.

When introduced into the body substances or drugs activated forms of ultra-low doses of antibodies to it contribute to the reduction occurring as a consequence of pathological syndromes (acute or chronic intoxication, postintoksikatinom disorders, addiction).

1. A method of treating a pathological syndrome by introducing into the body of activated forms of ultra-low doses of antibodies, prepared according to homeopathic technology, antigen - substance, affecting the formation mechanisms of pathological syndrome.

2. The method according to p. 1, wherein the antigen is a substance that causes intoxication and/or dependence.

3. A method of treating a pathological syndrome by introducing into the body of activated forms of ultra-low doses of antibodies, prepared according to homeopathic technology, hapten - substance, anywherefrom with high molecular compound having an impact on the formation mechanisms of pathological syndrome.

4. A method of treating a pathological syndrome by introducing into the body of activated forms of ultra-low doses of antibodies, prepared according to homeopathic technology, antigen - matter tissue or tissue culture, influencing the formation mechanisms of pathological syndrome mainly in this tissue.

5. The method of treatment according to any one of paragraphs.1-4, characterized in that use is Astia.

6. The method of treatment according to any one of paragraphs.1-3, in which the activated forms of ultra-low doses of antibodies to the antigen or hapten is introduced into the organism with this substance, affecting the formation mechanisms of pathological syndrome.

7. The method of treatment according to any one of paragraphs.1-4, in which the use of activated forms of ultra-low doses of antibodies to autologous antigens.

8. Drug for the treatment of pathological syndrome containing the activated form of sirmilik doses of monoclonal, polyclonal, or natural antibodies, prepared according to homeopathic technology, antigen - substance, affecting the formation mechanisms of pathological syndrome.

9. Drug under item 8, in which the use of activated forms of ultra-low doses of antibodies to substances of exogenous origin.

10. Drug under item 8, in which the use of activated forms of ultra-low doses of antibodies to substances of endogenous origin.

11. Drug under item 8, in which the use of activated forms of ultra-low doses of antibodies to antigens - substances fetal tissues or tissue culture.

12. Medicinal medium spans

 

Same patents:

The invention relates to new chemical substances with the General formula M'nM(H-1GluTrp)mn2Oh, where M' is a cation of an alkali metal, M is a cation d-metal or alkaline-earth metal, GluTrp - anion glutamylation, n is the number of atoms of alkali metal, m is the number of water molecules

The invention relates to medicine, in particular for therapy and for the treatment of pathological conditions in which it participates, including an excess of bradykinin

The invention relates to medicine, namely to infectious diseases, in particular to the treatment of hemorrhagic fever with renal syndrome (HFRS)

The invention relates to new derivatives of 2-renominate General formula (I), where R1and R2represent hydrogen, C1-C6-alkyl, deformity, trifluoromethyl, C3-C6-cycloalkyl, saturated 5-membered heterocycle containing one oxygen atom, indanyl, 6,7-dihydro-5H-cyclopentadienyl or1-C6-alkyl, substituted phenyl, indayla or3-C6-cycloalkyl, R3is hydrogen, R4represents hydrogen, halogen, C1-C6-alkyl, trifluoromethyl, or R4represents a radical of the formula-O-R7where R7is hydrogen, R5represents hydrogen or R4and R5taken together may form a bivalent radical of formula-CH2-CH2-O-CH2-CH2-, R6represents hydrogen or C1-C6-alkyl, -a-b - represents a bivalent radical of the formula- (CR10= CR11or СНR10-СНR11where each R10and R11independently represents hydrogen or C1-C6-alkyl, L represents hydrogen, C1-C6-alkyl, C1-C6-allyloxycarbonyl,1-C6-alkyl, substituted by one or two penilai

The invention relates to medicine, in particular to the field of pharmacology, medicinal substances used for the prevention and treatment of diseases, the mechanisms of pathogenesis are the primary biochemical links are release from the depot of histamine and/or hyperactivation of free radical process

The invention relates to medicine, in particular for experimental Oncology, and for the treatment of malignant tumors

The invention relates to medicine, namely to obtain drugs used for the treatment of primary and secondary immunodeficiencies
The invention relates to medicine, in particular to Allergology, to methods for treating allergies

The invention relates to a new compound - derived 4-oxo-1,4-dihydropyrimidin formula I, having antihypoxic, cerebroprotective and immunotropic activity, and may find application in medicine

The invention relates to veterinary medicine, namely to epizootiology and veterinary immunology and AIDS for specific passive prophylaxis and treatment of associated viral-bacterial infections

The invention relates to medicine and relates to drugs to prevent transplant rejection, monoclonal antibodies to the CD3 antigen of T-lymphocytes person, hybridoma producing these antibodies, and treatment of patients with reaction acute transplant rejection after kidney transplantation
The invention relates to medicine, namely to obtain immunobiological medicinal products used for the correction of immune disorders of various origins (prevention and relief of crises of transplants of organs, as well as the treatment of aplastic anemia, fight with purulent-septic conditions, etc

The invention relates to medicine and biotechnology and includes soluble polypeptide fraction protein LAG-3, a method of obtaining a therapeutic composition and the antibody

The invention relates to medicine

The invention relates to medicine, in particular immunology, and can be used for immunoprophylaxis and immunotherapy of diphtheria

The invention relates to medicine, in particular for Microbiology, and the receipt antitoxoplasma immunoglobulin to detect Toxoplasma in pathological material direct fluorescent antibody (IFA)
The invention relates to medicine, namely to the treatment of infectious diseases, and can be used in the treatment of patients with tick-borne encephalitis with immunoglobulin

The invention relates to immunology and concerns antiidiotypic antibodies, which induce an immune response against the receptor of the epidermal growth factor

FIELD: genetic engineering, immunology, medicine.

SUBSTANCE: invention relates to new antibodies directed against antigenic complex CD3 and can be used in therapeutic aims. Antibody IgG elicits the affinity binding with respect to antigenic complex CD3 wherein heavy chain comprises skeleton of the human variable region in common with at least one CD3 taken among amino acid sequences SEQ ID NO 2, 4 and 6 and their corresponding conservatively modified variants. Light chain comprises skeleton of the rodent variable region in common with at least one CD3 taken among amino acid sequences SEQ ID NO 8, 10 and 12 and their corresponding conservatively modified variants. Antibody is prepared by culturing procaryotic or eucaryotic cell co-transformed with vector comprising recombinant nucleic acid that encodes antibody light chain and vector comprising recombinant nucleic acid that encodes antibody heavy chain. Antibody is administrated in the patient suffering with malignant tumor or needing in immunosuppression in the effective dose. Invention provides preparing chimeric antibodies against CD3 that are produced by expression systems of procaryotic and eucaryotic cells with the enhanced yield.

EFFECT: improved preparing methods, valuable medicinal properties of antibody.

33 cl, 5 dwg, 1 ex

Up!